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ABSTRACT OF DISSERTATION  
 
 
 
 
 
THE MESOCORTICOLIMBIC DOPAMINE PATHWAY RECONSTITUTED IN 
VITRO: GLUTAMATE RECEPTORS AND CORTICOSTEROID-
METHAMPHETAMINE NEUROTOXICITY 
Stress promotes the use of methamphetamine and other recreational substances and is 
often implicated in relapse to stimulant use. Thus, it is of critical importance to examine 
the consequences of the co-occurance of stress and methamphetamine use.  Activity of 
the glutamatergic N-methyl D-aspartate (NMDA) receptor system appears to be involved 
in the neurotoxic effects of both chronic stress and methamphetamine exposure.  The 
current studies investigated the hypothesis that chronic pre-exposure to the stress 
hormone corticosterone (CORT) results in an increase of NMDA receptor activity and 
that this will potentiate the neurotoxic effects of methamphetamine (METH).   Co-
cultures of the ventral tegmental area, nucleus accumbens, and medial prefrontal cortex 
were pre-exposed to CORT (1 μM) for 5 days prior to co-exposure to METH (100 μM) 
for 24 hours to investigate the combined effects on neurotoxicity and protein density of 
NMDA receptor subunits.  The combination of CORT and METH resulted in significant 
neurotoxicity within the medial prefrontal cortex compared to either CORT or METH 
alone.  The CORT+METH-induced toxicity was attenuated by co-exposure to the NMDA 
receptor antagonist (2R)-amino-5-phosphonovaleric acid (APV; 50 μM) during the 24 
hour CORT and METH co-exposure.  Although CORT alone did not significantly alter 
the density of the NR1 and NR2B subunits of the NMDA receptor, METH exposure for 
24 hours resulted in a significant loss of the polyamine sensitive NR2B subunit.  Co-
exposure to CORT and METH also resulted in decreased extracellular glutamate while 
not significantly altering extracellular dopamine.  These results suggest an enhancement 
of NMDA receptor systems or downstream effectors in areas of the mesolimbic reward 
pathway following chronic pre-exposure to CORT, which leads to enhanced neuronal 
vulnerability to future excitotoxic insults.  This may be of critical importance as use of 
 
 
psychostimulants such as METH and other drugs of abuse may produce excitotoxic 
events in these areas, thus further compromising neuronal viability. 
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Chapter 1 
INTRODUCTION 
Stress and Substance Abuse 
Psychological and physical stressors often precede and accompany substance 
abuse as well as precipitate relapse.  Individuals with a history of substance abuse often 
report stress and negative mood states as reasons for relapse and continued abuse of 
substances (Jacobsen, Southwick, & Kosten, 2001).  High rates of co-morbidity between 
post-traumatic stress disorder (PTSD) and substance abuse disorders were first reported 
in war-related studies; in these investigations,  as many as 75% of combat veterans 
diagnosed with lifetime PTSD also reported substance abuse or dependence (Jacobsen, et 
al., 2001).  Furthermore, an earlier study revealed that adolescents who reported physical 
and sexual abuse were more likely to use alcohol and marijuana, were more likely to 
abuse multiple substances, and reported earlier initiation of drug use compared to their 
non-abused counterparts (Harrison, Fulkerson, & Beebe, 1997).  A longitudinal study 
conducted with young adults found that those diagnosed with PTSD were nearly five 
times more likely to develop drug abuse or dependence during the 12-month assessment 
interval than those experiencing no trauma (Reed, Anthony, & Breslau, 2007).  Indeed, 
several studies have noted increased use of psychostimulants such as cocaine and 
amphetamine in individuals diagnosed with PTSD or anxiety disorders (Sareen, Chartier, 
Paulus, & Stein, 2006; Solomon, Kiang, Halkitis, Moeller, & Pappas, 2010). A recent 
study investigating the use of crystal methamphetamine found that individuals diagnosed 
with PTSD were significantly more likely to report previous crystal methamphetamine 
use, began use at an earlier age, and use crystal methamphetamine over five times longer 
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than their trauma-exposed, non-PTSD counterparts (Smith, Blumenthal, Badour, & 
Feldner, 2010). Further, acute administration of the stress hormone cortisol elicited 
increased subjective ratings for craving in cocaine-dependent individuals (Elman, Lukas, 
Karlsgodt, Gasic, & Breiter, 2003).  In addition, images of personal stressors increased 
ratings of anxiety and drug craving in cocaine-dependent individuals, abstinent 
alcoholics, and in naltrexone-treated opiate-dependent individuals (Sinha, 2007).  
Collectively, these studies demonstrate the high rate of co-morbidity between stress 
disorders such as PTSD and substance abuse.  
Preclinical research with animal models lends further support for the link between 
stress and substance abuse. Rodent models employing intermittent stressors, such as 
footshock or forced swim periods, have been shown to produce cross-sensitization to 
many psychostimulant drugs and enhance the rewarding properties associated with these 
drugs of abuse (as reviewed in Yap & Miczek, 2008).  Additionally, exposure to physical 
stressors has been shown to facilitate the acquisition of psychostimulant self-
administration (Kosten, Miserendino, & Kehoe, 2000; Piazza, Deminiere, le Moal, & 
Simon, 1990).  Additionally, exposure to an acute stressor (i.e. footshock) can induce 
reinstatement of drug-seeking behavior for many drugs of abuse (for reviews, see Cleck 
& Blendy, 2008; Yap & Miczek, 2008).  Further evidence of the interaction between 
stress and psychostimulant intake in preclinical models is often found in studies involving 
enriched (i.e. social cagemates and novel toys) versus isolated rearing conditions.  
Several studies have noted increased amphetamine self-administration and increased 
amphetamine-induced locomotor sensitization in rats raised under isolated conditions as 
opposed to enriched conditions (Bardo et al., 1995; Bardo, Klebaur, Valone, & Deaton, 
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2001; for a review, see Stairs & Bardo, 2009).  Additional studies have suggested that the 
increased amphetamine self-administration observed in socially isolated rodents may be 
mediated by stress and the glucocorticoid receptor (Stairs, Prendergast, & Bardo, 2011).  
Taken together, both human and rodent studies suggest that high levels of stress may play 
a role both in the initiation of substance use and in relapse.  
Mesocorticolimbic Dopamine Reward Pathway 
The primary reinforcing effects of all drugs of abuse, as well as all natural 
reinforcers (i.e. food, water, sex), are thought to be dependent, at least in part, on the 
mesocorticolimbic dopaminergic reward pathway.  This pathway consists of 
dopaminergic projections from the ventral tegmental area (VTA) to the nucleus 
accumbens (NAcc), which is subdivided into the core and shell.  Broadly speaking, this 
pathway also contains glutamatergic and GABAergic fibers that project from limbic 
structures such as the hippocampus, amygdala, and medial prefrontal cortex (mPFC) to 
the NAcc as well as dopaminergic tracts that project from the VTA to the aforementioned 
limbic structures (for a review, see Fields, Hjelmstad, Margolis, & Nicola, 2007; Pierce 
& Kumaresan, 2006).  Although the VTA contains both GABAergic and glutamatergic 
neurons that project to the NAcc and other limbic regions, it is the neurotransmitter 
dopamine (DA) and the dopaminergic projections to the NAcc which have been the focus 
of many studies investigating the rewarding effects of drugs of abuse.   Early studies 
revealed that direct stimulation of the VTA or NAcc is rewarding such that these areas 
sustain intra-cranial self-stimulation, ICSS (Fibiger & Phillips, 1988; Robbins & Everitt, 
1996).  Activation of the mesocorticolimbic pathway leads to increased DA levels most 
often in the NAcc, but also in the prefrontal cortex (PFC).  It is this increase in DA which 
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is thought to be responsible for the rewarding and pleasurable feelings associated with a 
stimulus (Addolorato, Leggio, Abenavoli, & Gasbarrini, 2005).  In sum, the 
mesocorticolimbic pathway and resultant rise of DA in the NAcc appear to be critical for 
all reinforcers. 
Glutamate receptors: Structure and Function 
Glutamate (GLUT) is the major excitatory neurotransmitter in the mammalian 
brain and activates both ionotropic and metabotropic receptors.  While the metabotropic 
receptors produce actions via G-proteins (linked to these receptors) to possibly release 
intracellular stores of calcium (Ca
2+
), ionotropic receptors act via ion channels to allow 
Ca
2+
, sodium (Na
+
), and/or potassium (K
+
) to flow into the cell.  The glutamatergic 
ionotropic family of receptors includes the kainate receptor, the 2-amino-3(3-hydroxy-5-
methylisoxazol-4-yl) proprionate (AMPA) receptor, and the N-methyl-D-aspartate 
(NMDA) receptor.  
AMPA receptors are heteromeric structures composed of four different subunits, 
GluR1-4, which usually combine to form heterotetramers.  Each subunit consists of a 
membrane region with three transmembrane domains (TM1, 3, and 4) and a second 
domain which loops back within the membrane and comes out the intracellular side (M2).  
Thus, each subunit has an extracellular N-terminal domain and an intracellular C-terminal 
domain.   Of the four subunits, it is only the GluR2 subunit that can undergo RNA editing 
in the second membrane to produce a positively charged arginine (R) residue as opposed 
to the neutral glutamine (Q) residue that is present on unedited GluR2 subunits (Jonas & 
Burnashev, 1995).  This editing of the GluR2 subunit mediates the receptor’s 
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permeability to Ca
2+
 and other ions (Jonas & Burnashev, 1995).   In particular, receptors 
missing the GluR2 subunit exhibit a high permeability to Ca
2+
 and other cations, while 
receptors containing the edited GluR2, and therefore the arginine residue, are 
impermeable to Ca
2+
 (Jonas & Burnashev, 1995).  Previously it was thought that all 
AMPA receptors were impermeable to Ca
2+
; however, it is now known that this is not the 
case as AMPA receptor antagonists have been shown to be neuroprotective against Ca
2+
-
induced excitotoxicity (for a review, see Gill & Lodge, 1997).   The AMPA receptor is 
blocked by polyamines under resting conditions and is only opened when the membrane 
becomes depolarized to reach the threshold for an action potential.  Once the polyamine 
blockade is removed, the ion channel opens to allow Na
+
 (and Ca
2+
, if applicable) into the 
cell.  This further depolarizes the cell and can lead to activation of the NMDA receptor, 
as AMPA and NMDA receptors are often co-localized in the cell membrane.  This close 
proximity between AMPA and NMDA receptors is important in memory processes such 
as long-term potentiation (LTP) and long-term depression (LTD; for a review, see Wheal 
et al., 1998).   
The kainate receptors, although not yet well characterized, are thought to be made 
up of tetramers comprised of various subunits including GluR5-7 and KA1-2 (for a 
review, see Heath & Shaw, 2002).  Structurally, each subunit is thought to be 
homologous to the subunits of the AMPA receptor (Sattler & Tymianski, 2001).  The 
GluR5-7 subunits have a relatively low affinity for kainate as compared to the high-
affinity KA1 and KA2 subunits (reviewed in Lodge, 2009).  The high-affinity KA1 and 
KA2 receptor subunits cannot form functional receptors alone but can combine with 
GluR5 or GluR6 to form functional receptors (Lodge, 2009).  Similar to the GluR2 
6 
 
subunit of the AMPA receptor, GluR5 and GluR6 can undergo RNA (Q/R) editing in 
transmembrane domain 2; this editing is thought to mediate the channel’s permeability to 
Ca
2+
 (Pinheiro & Mulle, 2006).  The kainate receptors have been shown to both facilitate 
and inhibit the synaptic release of GLUT when kainate receptors are found on the 
presynaptic nerve cell and thus serve as autoreceptors (see Jane, Lodge, & Collingridge, 
2009 for a review).   
NMDA receptors are ionotropic glutamatergic receptors which are tetramers 
made up of two essential NR1 subunits and two regulatory subunits composed of NR2A-
D and/or NR3A-B subunits, although NR2A and NR2B are the most commonly 
expressed regulatory subunits (for a review, see Cull-Candy, Brickley, & Farrant, 2001).  
Structurally, the subunits are similar to AMPA receptor subunits, each possessing four 
membrane domains (3 transmembrane-spanning domains and one membrane domain that 
loops back around), an extracellular N-terminal domain, and an intracellular C-terminal 
domain (as reviewed in Paoletti & Neyton, 2007).  The ion channel is blocked (voltage-
dependently) by Mg
2+
, which is removed via membrane depolarization to allow Ca
2+
 and 
a small amount of Na
+
 into the cell (Lynch & Guttmann, 2001).  As noted earlier, AMPA 
receptor depolarization is a common mechanism by which the Mg
2+
 blockade is removed.  
Glycine serves as a co-agonist at the NMDA receptor and must be bound to the NR1 
subunit before the receptor is fully activated; however, the GLUT binding site is located 
on the NR2 subunit and must also be bound (Paoletti & Neyton, 2007).  Thus, the 
opening of the NMDA receptor ion channel requires three distinct events: removal of the 
Mg
2+
 blockade, glycine binding, and GLUT binding (Lynch & Guttmann, 2001).  
Polyamines, protons, and extracellular Zn
2+
 also act allosterically to modify receptor 
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selectivity (Cull-Candy, et al., 2001).  NMDA receptor antagonists, such as MK-801, 
ketamine, and phencyclidine (PCP), are ion channel blockers which are non-competitive 
with NMDA (Lynch & Guttmann, 2001).   
While the NR2 and NR3 subunits are regulatory, the NR1 subunit is essential for 
functional NMDA receptors. Genetic deletions of the NR1 subunit have proven to be 
lethal within the early postnatal period (Forrest et al., 1994).  In contrast, deletion of the 
NR2A subunit in mice resulted in survival and normal developmental appearance 
(Sakimura et al., 1995).  Previous research has also shown the NR1 subunit to be 
essential for immediate GLUT- and NMDA-mediated toxicity (Tokita et al., 1996).  
Alongside the various sensitivities of the NR1 receptor, each NR2 subunit also has 
distinctive sensitivities which give rise to the many combinations of various receptor 
subtypes.  Specifically, the NR2 receptor subunits each exhibit different sensitivities to 
the Mg
2+
 block, polyamines, glycine, and GLUT affinity (Kutsuwada et al., 1992; 
Monyer et al., 1992; Sharma & Reynolds, 1999; Stern, Behe, Schoepfer, & Colquhoun, 
1992).  The NR1 subunit has a total of eight functional splice variants, each of which has 
a different sensitivity to agonist, antagonists, Ca
2+
 and other ions, as well as one 
nonfunctional splice variant (see Zukin & Bennett, 1995 for a review).  An asparagine 
residue (N598) found on the second membrane domain on both NR1 and NR2 subunits 
regulates the permeability to Ca
2+
, Mg
2+
, Na
+
, polyamines, and Zn
2+
, with contrasting 
effects on the NR1 and the NR2 subunit (Burnashev et al., 1992; Schneggenburger & 
Ascher, 1997; Traynelis, Burgess, Zheng, Lyuboslavsky, & Powers, 1998).  Specifically, 
replacing the asparagine residue with a glutamine residue on the NR1 was found to 
slightly reduce the Mg
2+ 
blockade and decrease Ca
2+
 permeability, while the same 
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replacement on the NR2 did not significantly affect Ca
2+
 permeability but did increase 
Mg
2+
 permeability and more strongly reduced the Mg
2+
 blockade (Burnashev, et al., 
1992).   
Each NMDA receptor subunit demonstrates differences in their intracellular C-
terminal domain sequence, which is thought to mediate the interaction of the NMDA 
receptor and various intracellular cytoskeletal and synaptic proteins (for reviews, see 
Arundine & Tymianski, 2004; Forder & Tymianski, 2009).  The NMDA receptor and 
related proteins make up a large multiprotein structure located beneath the postsynaptic 
membrane known as the postsynaptic density (PSD).  Postsynaptic density proteins are 
involved in various functions, including regulation of receptor clustering, modulation of 
receptor function, and cell to cell bonding (Forder & Tymianski, 2009).  Moreover, there 
are four key types of molecules within the PSD including cytoskeletal, membrane-bound, 
modulatory enzymes, and scaffolding proteins (Forder & Tymianski, 2009).  The 
interactions between the NMDA receptor and PSD proteins are highly specific, indicating 
that these interactions connect the NMDA receptor to particular downstream signaling 
molecules (Arundine & Tymianski, 2004).    
Dopamine and Glutamate Interactions 
There is also evidence of interactions between dopaminergic and glutamatergic 
neurons within the mesocorticolimbic pathway.  Although this pathway is primarily 
thought to be DA-mediated, fewer than 60% of VTA neurons in the rat brain are 
dopaminergic (Margolis, Lock, Hjelmstad, & Fields, 2006).  In addition to dopaminergic 
projections, the VTA is also thought to contain GABAergic and glutamatergic neurons 
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projecting to the NAcc, PFC, and other structures (Carr & Sesack, 2000; Chuhma et al., 
2004; Kawano et al., 2006; Mendez et al., 2008; Van Bockstaele & Pickel, 1995). 
Additionally, a recent study found that the PFC and NAcc receive GLUT-only and 
GLUT-DA inputs from the VTA, paralleling the dopaminergic tracts (Yamaguchi, Wang, 
Li, Ng, & Morales, 2011).  One theory that has been postulated in recent years is that 
GLUT is a co-transmitter in DA-releasing neurons (Fields, et al., 2007).  Consistent with 
this theory, studies have found that activation of VTA neurons can produce glutamatergic 
excitatory postsynaptic potentials in medial spiny neurons of the NAcc, indicating that 
DA and GLUT may be co-released (Chuhma, et al., 2004; Hnasko et al.; Stuber, Hnasko, 
Britt, Edwards, & Bonci, 2010).  One recent study found that GLUT co-release promotes 
the growth and survival of mesencephalic DA neurons in mice, as evidenced by a 
reduction in the density of DA innervation to the ventral striatum as well as a decrease in 
basal extracellular DA levels in mice with a conditioned deletion of the vGLUT2 gene in 
DA neurons (Fortin et al., 2012).  Further, the DA-GLUT interaction may depend on the 
NMDA receptor, as stimulation of prefrontal glutamatergic NMDA receptors dose-
dependently reduced basal and stimulated DA release in the PFC (Del Arco & Mora, 
2001), whereas blockade of the NMDA receptors increased levels of basal DA and DA 
metabolites in the NAcc (Del Arco, Segovia, & Mora, 2008).  Additionally, chronic 
antagonism of DA neurons in vitro with AMPA/kainate, NMDA, and mGluR antagonists 
showed that the NMDA receptor, but not AMPA/kainate or metabotropic GLUT 
receptor, antagonism decreased the number of tyrosine hydroxylase-positive DA 
mesecephalon neurons (Fortin, et al., 2012).  These studies suggest that GLUT, and the 
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NMDA receptor in particular, may be modulating DA activtiy within areas of the 
mesocorticolimbic pathway.   
Mechanisms of Stress-induced Changes in the Brain 
Stress activates the hypothalamus-pituitary-adrenal (HPA) axis by stimulating the 
paraventricular nucleus of the hypothalamus to release corticotropin releasing hormone 
(CRH) and arginine vasopressin onto the anterior pituitary.  These hormones act 
synergistically to stimulate the release of adrenocorticotropic hormone (ACTH).  ACTH 
then travels from the pituitary gland to the cortex of the adrenal gland via the 
bloodstream.  The adrenal cortex then synthesizes and releases stress hormones known as 
corticosteroids into the bloodstream.  These hormones include cortisol in humans and the 
equivalent primary corticosteroid hormone corticosterone (CORT) in rodents.  
Corticosteroids are highly lipophilic and can easily penetrate the cell membrane to bind 
to intracellular receptors in the hypothalamus, pituitary gland, PFC, or hippocampus to 
suppress the secretion of CRH and ACTH, thus creating a negative feedback loop.  There 
are two known intracellular corticosteroid receptors as first defined by Reul and de Kloet 
(1985).  The type I, or mineralocorticoid (MR), high-affinity receptor is localized within 
the hippocampus and the cortex.  The type II, or glucocorticoid (GR), receptor is found 
ubiquitously throughout the brain in neurons and glial cells.  CORT has nearly a ten-fold 
higher affinity for the MR (KD = 0.5 nM) than the GR (KD = ~2.5-5 nM; Reul & de 
Kloet, 1985).  The high-affinity MR is fully occupied at low concentrations of CORT; 
however, when CORT levels rise (i.e. under stressful conditions), the GR becomes 
occupied (Reul & de Kloet, 1985).  In previous work, it was found that dexamethasone, a 
GR-selective agonist, produced region-specific neuronal loss in the hippocampus (Sousa, 
11 
 
Paula-Barbosa, & Almeida, 1999).  Additionally, it has been suggested that activation of 
the MR may promote neuronal survival and function, whereas activation of the GR may 
be involved in neuronal degeneration (Gould, Woolley, & McEwen, 1990; Hassan, von 
Rosenstiel, Patchev, Holsboer, & Almeida, 1996; Sousa, et al., 1999); thus, the damaging 
effects caused by chronic, high levels of CORT are likely mediated, at least in part, by 
GR activation.   
Although intracellular receptor binding has long been accepted as the primary 
model of steroid actions, recent evidence suggests that plasma membrane-bound 
receptors may be responsible for non-classical, non-genomic actions of steroid hormones 
(as reviewed in Moore & Evans, 1999).  In particular, the classic genomic model of 
steroids could not account for effects that were very rapid, steroid effects that occurred 
after RNA and/or protein synthesis was blocked, or effects that remained after steroid 
conjugation with bovine serum albumin (BSA) thereby rendering the steroid 
impermeable to the plasma membrane (Moore & Evans, 1999).  Plasma membrane-
bound CORT receptors have been identified in the amphibian (Orchinik, Murray, & 
Moore, 1991), avian (Breuner & Orchinik, 2009), and mammalian brain (Orchinik, 
Hastings, Witt, & McEwen, 1997).  CORT has been shown to increase spontaneous 
action current frequency in the rat paraventricular nucleus independent of GR activation 
(Zaki & Barrett-Jolley, 2002) and BSA-conjugated CORT has been shown to acutely 
enhance NMDA-induced Ca
2+
 elevations in cultured hippocampal neurons (Takahashi et 
al., 2002).  Additionally, the CORT-induced enhanced locomotor activity was not 
attenuated by either a protein synthesis inhibitor or intracellular MR/GR antagonists 
(Sandi, Venero, & Guaza, 1996). 
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Glucocorticoids have also been shown to exert effects within the 
mesocorticolimbic pathway.  Many studies have investigated the effects of chronic stress 
on DA release within areas of the mesocorticolimbic DA reward pathway using in vivo 
microdialysis.  Research has shown stress-induced reductions in both the dopamine 
transporter (DAT) and in vesicular monoamine transporter 2 (VMAT2) function in 
rodents exposed to daily swim stress for 3 weeks (Zucker, Weizman, & Rehavi, 2005).  
Piazza and colleagues (1993) showed that animals will self-administer various doses of 
CORT (25-50 μg/infusion), including doses that result in CORT plasma concentrations 
comparable to those observed during stressful conditions (i.e. those during restraint 
stress; 35-45 μg/100 ml).  Intermittent tail-shock stress has also been shown to increase 
the amount of extracellular DA found in the NAcc, striatum, and medial frontal cortex 
(125-195% basal conditions; Abercrombie, Keefe, DiFrischia, & Zigmond, 1989).  
Further, Tidey and Miczek (1996a) showed that animals exposed to stressors (i.e. 
previous social defeat stress) had increased mesocorticolimbic DA release (~160% 
baseline in NAcc and PFC) during social threat.  Similarly, extracellular levels of DA in 
the NAcc shell, but not the core, were increased in rats immediately following a mild 
footshock stressor (Kalivas & Duffy, 1995).  Removal of endogenous glucocorticoids, via 
adrenalectomy, resulted in decreased extracellular DA concentrations in the NAcc shell 
(but not the NAcc core), both at baseline conditions as well as following either a stress or 
cocaine challenge (Barrot et al., 2000).  Although the exact mechanism behind CORT-
induced DA release is not well understood, it may, at least in part, be mediated by 
corticosteroid receptors found on VTA neurons within the mesocorticolimbic DA reward 
pathway (Harfstrand et al., 1986; Piazza, et al., 1993).  Further, administration of a MR 
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antagonist had no effect on basal DA in the shell of the NAcc, while administration of a 
GR antagonist resulted in decreased basal DA levels in a dose-dependent manner in the 
same area (Marinelli, Aouizerate, Barrot, Le Moal, & Piazza, 1998).  Taken together, 
these results indicate that glucocorticoids can produce increases in extracellular DA 
content within the shell of the NAcc via the GR.   
Although the DA pathway appears to be involved in mediating the effects of 
chronic stress, stress is also thought to exert effects on the glutamatergic NMDA 
receptor.  The ionotropic glutamatergic NMDA receptor is highly permeable to Ca
2+
 and 
thought to be involved in several models of Ca
2+
-dependent excitotoxicity, including 
ischemia/hypoxia, traumatic brain injury, and the effects of ethanol withdrawal.  Both 
metabotropic and ionotropic GLUT receptors, and in particular the NMDA receptor and 
the NMDA receptor 2B subunit (NR2B), have been shown to mediate glucocorticoid-
induced apoptosis in hippocampal cultures (Lu, Goula, Sousa, & Almeida, 2003).  Lu et 
al. showed that the GR agonist dexamethasone (1 μM) produced significant apoptotic 
toxicity; this effect was significantly attenuated by a 15-min pretreatment with either 
MK801 (general NMDA receptor antagonist; 10 μM) or ifenprodil (an antagonist at the 
NR2B subunit; 10 μM).  Chronic CORT has been shown to increase levels of mRNA for 
the NMDA receptor subunits 2A and 2B (NR2A and NR2B, respectively), suggesting 
that the effect of CORT on the hippocampal formation is mediated, at least in part, by the 
NMDA receptor (Weiland, Orchinik, & Tanapat, 1997).  Previous research has also 
shown that while exposure to low levels of CORT is not toxic alone, when given in 
conjunction with other toxic agents (i.e. NMDA receptor agonist), there is an additive 
effect of cytotoxicity in the organotypic hippocampal slice culture model (Mulholland, 
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Self, Harris, Littleton, & Prendergast, 2004a; Mulholland et al., 2006).  Further, chronic 
stress (i.e. unpredictable stress twice per day for 3 weeks) resulted in enhanced 
vulnerability to CORT-induced excitation in the dentate gyrus of the hippocampus (Karst 
& Joels, 2003).  Interestingly, acute CORT has previously been shown to prolong NMDA 
receptor mediated Ca
2+
 signaling (Takahashi, et al., 2002).  Collectively, these results 
demonstrate the wide range of effects induced by CORT on both dopaminergic and 
glutamatergic signaling.   
Research has also shown that stress may produce changes in numerous 
transcription factors, or proteins which bind to DNA and are involved in the regulation of 
gene transcription from DNA to mRNA. In particular, the leucine zipper family of FOS 
proteins including c-Fos, Fos B, and ΔFos B are all thought to be affected by stress (for a 
review, see Miczek et al., 2011).  Several studies have indicated that acute stress (i.e. 
restraint stress) enhances c-Fos mRNA expression in the hippocampus, cortex, 
hypothalamus, septum and brainstem (Melia, Ryabinin, Schroeder, Bloom, & Wilson, 
1994; Senba & Ueyama, 1997); however, this effect appears to become desensitized 
following repeated stress (Melia, et al., 1994). In contrast, acute restraint stress increased 
immunoreactivity of Fos B in limbic areas of the hypothalamic paraventricular nucleus 
and the ventrolateral septum, while chronic restraint stress (i.e. nine days of repeated 
restraint stress) also led to elevations of Fos B immunoreactivity in the lateral septum and 
the basolateral and medial amygdala (Stamp & Herbert, 2001; Stamp & Herbert, 1999).  
More recent studies from the laboratory of Dr. Eric Nestler have demonstrated that ΔFos 
B, the truncated form of Fos B, is also involved in mediating the effects of chronic stress. 
Perrotti and colleagues (2004) found that c-Fos, Fos B, and ΔFos B were increased in the 
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frontal cortex and NAcc following acute restraint stress.  Similar to previous findings, 
western blot analysis showed that the production of c-Fos and full-length Fos B was 
desensitized following chronic (10 days) restraint stress, while ΔFos B levels remained 
elevated at this time (Perrotti, et al., 2004).  Further probing via immunohistochemistry 
studies revealed that ΔFos B expression was increased in the PFC, NAcc core and shell, 
basolateral nucleus of the amygdala, and lateral septum following chronic stress (Perrotti, 
et al., 2004).  Recently, the glutamatergic AMPA receptor subunit, GluR2, has been 
implicated in mediating the effects of chronic stress on ΔFos B expression, as mice 
resilient to the deleterious effects of stress have both increased ΔFos B expression and 
higher AMPA receptor subunit GluR2 expression in the NAcc (Vialou et al., 2010).  
Taken together, these studies illustrate the effects of stress on the FOS family of 
transcription factors within areas of the brain critical to reward.  
In addition to the effects of stress on the FOS family of transcription factors, 
stress can also affect the transcription factor cAMP response element-binding protein 
(CREB; for a review, see Carlezon, Duman, & Nestler, 2005). Similar to the pattern seen 
with c-Fos, acute stress appears to activate CREB in a GR-dependent manner, resulting in 
increased levels of phosphorylated CREB (pCREB; Legradi, Holzer, Kapcala, & Lechan, 
1997), while chronic mild footshock stress appears to cause a reduction in pCREB levels 
in areas such as the PFC and other cortical regions (Trentani, Kuipers, Ter Horst, & Den 
Boer, 2002).  Previous research has also revealed a biphasic pCREB response in limbic 
areas in response to an acute forced swim stressor, such that an early peak in pCREB 
immunoreactivity was found around 15 minutes post-stressor, which was then followed 
by a steep reduction and subsequent secondary rise 6-8 hours post-stressor (Bilang-
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Bleuel, Rech, De Carli, Holsboer, & Reul, 2002).  Further studies have shown that acute 
stressors may also produce increased levels of CREB in areas of the mesocorticolimbic 
reward pathway, including the NAcc shell (Barrot et al., 2002).  Additionally, CREB 
phosphorylation in response to an acute ischemic event was found to be NMDA receptor 
dependent, as pretreatment with MK-801 attenuated the ischemic-induced increase in 
pCREB within the hippocampus (Mabuchi et al., 2001).  These studies indicate that stress 
may alter CREB activity, along with other transcription factors and neurotransmitters, in 
regions of the brain critical to reward and possibly alter subsequent reward-related 
behaviors including responses to substances of abuse.  
Methamphetamine Abuse in the Clinical Population 
Methamphetamine (METH) abuse has become an increasingly evident problem in 
the United States, with nearly 500,000 past month users for non-medical purposes as well 
as over 125,000 new past year initiates in 2011 (Substance Abuse and Mental Health 
Services Administration, 2012).  Combining the rapid euphoric effects of METH and the 
ease of at-home production, illicit METH manufacturing and abuse has become a 
problem particularly in rural areas of the United States, including Kentucky (Kentucky 
State Police, 2010). METH use has been associated with multiple significant health 
concerns, including cardiovascular toxicity (i.e. myocardial infarction and 
atherosclerosis; for a review, see Darke, Kaye, McKetin, & Duflou, 2008), tooth decay 
(i.e. poor oral hygiene and METH mouth; Hamamoto & Rhodus, 2009), and a higher 
level of cerebrovascular incidents (i.e. increased risk of ischaemic and haemorrhagic 
stroke; Darke, et al., 2008).  The use of METH has also been associated with many 
central nervous system (CNS) abnormalities, including decreased hippocampal volume 
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(Thompson et al., 2004), decreased basal cerebral blood flow (Ances et al., 2011), and 
increased cortical gray matter loss in the frontal, occipital, temporal, and insular lobes 
(Nakama et al., 2011; Thompson, et al., 2004).  A recent study investigating 
neurotoxicity in METH abusers following death found a loss of striatal tyrosine 
hydroxylase (the rate limiting enzyme in dopamine synthesis), DAT, and VMAT2 
(Kitamura, 2009). Further, the loss of striatal DAT in chronic METH abusers has been 
reported to remain upwards of 3 years into abstinence (McCann et al., 1998; Volkow et 
al., 2001).  Although METH use is often associated with dopaminergic deficits 
(Kitamura, 2009), METH-dependent individuals who were abstinent for less than one 
month showed decreased frontal gray matter GLUT+glutamine concentrations (Ernst & 
Chang, 2008), suggesting craving during early abstinence may be due, in part, to depleted 
glutamatergic systems.  In addition, some of the CNS abnormalities have been correlated 
to decreased cognitive performance (Thompson, et al., 2004; van Holst & Schilt, 2011).  
Thus, METH abuse represents a serious public health concern with multiple 
psychological and physiological risks, and the mechanism by which METH produces 
neurological damage should be further examined.    
Mechanisms of METH-induced Changes in the Brain 
The primary reinforcing effect of psychostimulants, such as METH, is thought to 
be dependent on the mesocorticolimbic dopaminergic reward pathway.  Stimulants are 
thought to increase DA levels by preventing reuptake of DA from the synapse (White & 
Kalivas, 1998).  In two recent studies, it was shown that METH, amphetamine, and 
cocaine elevate the extracellular levels of DA in the NAcc, and that METH also increases 
extracellular levels of L-3,4-dihydroxyphenylalanine (DOPA), a precursor of DA (Izawa, 
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Yamanashi, Asakura, Misu, & Goshima, 2006; Shoblock, Maisonneuve, & Glick, 2003).  
METH is thought to substitute for monoamines at cell surface membrane-bound 
transporters including DAT, the noradrenaline transporter (NET), and the serotonin 
transporter (SERT; for a review, see Cruickshank & Dyer, 2009).  Although the natural 
function of these transporters is to remove excess neurotransmitter from the synapse, 
METH is thought to reverse DAT, NET, and SERT, resulting in increased levels of DA 
and other monoamines in the synapse.  METH works in a similar manner at the vesicular 
monoamine transporter 2 (VMAT2), which is responsible for packaging 
neurotransmitters into vesicles.  At this transporter, METH acts to produce increased 
levels of cytosolic monoamines and also acts at membrane-bound transporters to transfer 
these cytosolic monoamines into the synapse, resulting in increased DA, noradrenaline, 
and serotonin in the synaptic cleft available for post-synaptic receptor binding 
(Cruickshank & Dyer, 2009).  Importantly, METH is also a potent inhibitor of 
monoamine oxidase, which catabolizes DA and other monoamines, resulting in further 
increases in monoamine levels (Egashira, Yamamoto, & Yamanaka, 1987).  These 
studies demonstrate the importance of the mesocorticolimbic dopaminergic reward 
pathway in the reinforcing effects of METH and other psychostimulants. 
METH has also been shown to exert effects on glutamatergic signaling and 
receptors.  Previous studies have shown that high doses of METH result in increased 
extracellular GLUT content in the rodent striatum (Abekawa, Ohmori, & Koyama, 1994; 
Mark, Soghomonian, & Yamamoto, 2004; Nash & Yamamoto, 1992; Stephans & 
Yamamoto, 1994).  Further, investigations using western blot analysis revealed that 
subacute exposure to METH (4 mg/kg/day for 14 days) resulted in NMDA receptor 
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subunit 1 (NR1) upregulation in the frontal cortex, while both acute (8 mg/kg) and 
subacute exposure resulted in upregulation of NR1 in the striatum (Kerdsan, Thanoi, & 
Nudmamud-Thanoi, 2009).  Another recent immunoblotting study showed an 
upregulation of NR2A expression and no change in NR1 expression when METH was 
given acutely, and a downregulation of NR1 expression and no change in NR2A 
expression when METH was given in escalating doses (Simoes et al., 2007).  In contrast 
to the effects of CORT, short term METH given in conjunction with a NMDA receptor 
agonist had an antagonizing effect in hippocampal cultures, suggesting that acute METH 
acts as a functional antagonist at the NMDA receptor (Smith et al., 2007).  Accordingly, 
as the authors suggest, chronic NMDA receptor antagonism via METH may lead to 
compensatory NMDA receptor subunit upregulation and, hence, may increase 
vulnerability to further insults during METH withdrawal (Smith, et al., 2007).  Thus, it 
appears that METH may exert region-specific effects on glutamatergic signaling, 
possibly at the NMDA receptor.     
Similar to the effects seen with CORT, METH can also produce alterations in a 
number of transcription factors, including the FOS family.  Acute METH (1-40 mg/kg) 
has been repeatedly shown to induce widespread c-Fos in rodents within areas of the 
brain such as the NAcc, striatum, hypothalamus, thalamus, amygdala, frontal cortex, and 
hippocampus (Beauvais, Jayanthi, McCoy, Ladenheim, & Cadet, 2010; Thiriet, Zwiller, 
& Ali, 2001; Umino, Nishikawa, & Takahashi, 1995).  Further, the timecourse associated 
with increased c-Fos appears to be similar to that seen with acute CORT, in that with 
both events c-Fos levels revert back to control levels within 60 minutes (Thiriet, et al., 
2001).  The induction of c-Fos following acute METH has been reported to be dependent 
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on activation of D1 receptors (Beauvais, et al., 2010) as well as NMDA receptors (Ohno, 
Yoshida, & Watanabe, 1994).  A recent study demonstrated that, unlike the pattern seen 
with chronic CORT, chronic METH does not produce desensitization of c-Fos (Cornish, 
Hunt, Robins, & McGregor, 2012).  However, repeated METH (10 mg/kg every 2 hours 
x 4) did increase FosB expression threefold, although the response was delayed in 
comparison to that seen with c-Fos (Beauvais, et al., 2010).  Similar to the changes in c-
Fos, chronic METH self-administration (21 days) resulted in increased FosB expression 
in the VTA, amygdala, hypothalamus, and dorsal raphe (Cornish, et al., 2012); these 
changes were also postulated to be a result of increased ΔFos B due to the long-lasting 
nature. Although few studies have examined ΔFos B and METH, expression of ΔFos B is 
increased in the NAcc of rats following a three-day withdrawal from METH 
administration, suggesting a long-lasting change following METH administration 
(McDaid, Graham, & Napier, 2006).  In an elegant review of ΔFos B and drug addiction, 
Nestler et al. (2001) propose a timecourse for the activation of FOS family of 
transcription factors in response to drugs of abuse, with acute drug administration 
producing rapid increases in c-Fos (peak at 2 hours), followed by the induction of Fos B 
(~6 hours) and ΔFos B (up to 12 hours); in contrast, the authors propose an accumulation 
of ΔFos B over days or weeks following chronic drug administration.  These studies 
demonstrate the effects of psychostimulants, such as METH, on the expression of the 
FOS family of transcription factors in regions of the mesocorticolimbic reward pathway. 
In addition to affecting the FOS family of transcription factors, METH, like 
stress, can also affect the transcription factor CREB and pCREB.  An acute METH 
challenge in vitro (1-100 μM) dose-dependently increased CREB binding (Asanuma, 
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Hayashi, Ordonez, Ogawa, & Cadet, 2000).  Similar to the pattern seen with chronic 
CORT and CREB, chronic METH in vivo resulted in decreased expression of CREB in 
the rodent striatum (McCoy et al., 2011).  Expression of pCREB was increased in the 
frontal cortex of rats following a three-day withdrawal from chronic METH 
administration, but pCREB expression was decreased in the NAcc at 14 days withdrawal 
(McDaid, et al., 2006).  Although few studies have examined the interaction of pCREB 
and METH, one study showed that an acute cocaine challenge (10 mg/kg) increased 
pCREB levels in the NAcc (Walters, Kuo, & Blendy, 2003).  Further, increasing CREB 
expression in the shell of the NAcc produced an upward and leftward shift in the cocaine 
self-administration fixed ratio dose-response curve as well as increased progressive ratio 
for cocaine self-administration (Larson et al., 2011).  Taken together, these studies 
illustrate the possible biphasic effects of psychostimulants, like METH, on CREB 
expression as well as how increased CREB in brain areas of reward may affect 
subsequent drug abuse.  
METH Toxicity 
Chronic, high-dose METH abuse is often associated with dopaminergic and non-
dopaminergic deficits in multiple brain regions in the clinical population (see 
Methamphetamine Abuse in the Clinical Population section above), and many preclinical 
studies have also noted long-lasting METH-induced terminal damage with a large single 
dose or repeated high doses (see Krasnova & Cadet, 2009 for a review).  It has been 
postulated that METH toxicity (i.e. nerve terminal damage and apoptosis) is a 
consequence of numerous events, including oxidative stress via increased extracellular 
DA, excitotoxicity via increased extracellular GLUT, hyperthermia,  mitochondrial 
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dysfunction, neuroinflammatory responses, and endoplasmic reticulum stress (reviewed 
in Krasnova & Cadet, 2009; Yamamoto, Moszczynska, & Gudelsky, 2010).  The METH-
induced increase in extracellular DA may result in the formation of reactive oxygen 
species (ROS) and oxidative stress via auto-oxidation of DA, and administration of 
antioxidants has been shown to be protective against METH-induced dopaminergic 
terminal depletion (for reviews, see Kita, Wagner, & Nakashima, 2003; Krasnova & 
Cadet, 2009).  Multiple studies have shown that antagonists of the NMDA receptor such 
as MK-801 can attenuate the initial increase in extracellular DA and subsequent depletion 
of dopaminergic terminals following binge METH exposure (Boireau, Bordier, Dubedat, 
& Doble, 1995; Marshall, O'Dell, & Weihmuller, 1993; O'Callaghan & Miller, 1994; 
Ohmori, Koyama, Muraki, & Yamashita, 1993; Sonsalla, Riordan, & Heikkila, 1991), 
suggesting that both DA and GLUT may play a role in the nerve terminal degeneration 
produced by binge METH. 
In addition to a loss of monoaminergic terminals, METH is also thought to cause 
excitotoxicity and neuronal apoptosis (for a review, see Cadet, Jayanthi, & Deng, 2003).  
Although the exact mechanism of METH-induced apoptosis is unknown, it has been 
postulated that chronic METH leads to increased GLUT release and increased Ca
2+
 
signaling via the glutamatergic NMDA receptor, which then activates apoptotic cascades 
(i.e. calpains and caspases) leading to cell death (for a review, see Cadet & Krasnova, 
2009; Davidson, Gow, Lee, & Ellinwood, 2001).  Consistent with this theory, a recent 
review found that acute METH activates calpain and caspase cell death cascades in a 
manner similar to traumatic and ischemic brain injury in rodents (Gold et al., 2009).  
Further, a single dose of METH (10-40 mg/kg) produced significant increases in calpain 
23 
 
and caspase activation, as indicated by enhanced spectrin and tau protein fragments, 
respectively, in the rat cortex and hippocampus, with samples collected 24 hours after the 
highest dose of METH producing fragments equal to that seen in traumatic brain injury 
(Warren et al., 2005).  Additionally, blockade of the NMDA receptor prevented calpain 
and caspase-3 activation in a hippocampal model of traumatic brain injury (DeRidder et 
al., 2006).  Taken together, these studies implicate the NMDA receptor in both nerve 
terminal damage and apoptosis resulting from high-dose METH, suggesting it may be a 
potential target for METH-induced brain damage.  
Stress and METH 
It has long been suggested that stress and increased production of glucocorticoids 
may augment the effects of drugs of abuse by selectively enhancing DA release within 
the NAcc shell (for a review, see Marinelli & Piazza, 2002).  During times of chronic 
stress, an increase in glucocorticoids and DA (via repeated activation of the 
mesocorticolimbic DA reward pathway) may be a coping mechanism for the aversive 
effects associated with repeated stress and, thus, could lead to a sensitized state, leaving 
the organism more vulnerable to the drug-induced rewarding effects and subsequent 
addiction (Marinelli & Piazza, 2002).  In support of this theory, previous stress has been 
shown to enhance drug-induced behavioral responses such as locomotor activity and 
stereotypy, the acquisition and maintenance of drug self-administration, drug-induced 
conditioned place preference, and potentiate stimulant-induced striatal DA levels (see 
Briand & Blendy, 2010 for a review).  For instance, rodents exposed to repeated social 
defeat stress acquired cocaine self-administration in nearly half the time compared to 
their non-defeated counterparts, likely due to enhanced extracellular DA levels seen in 
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the NAcc (Tidey & Miczek, 1996b, 1997).  These studies suggest that prior exposure to 
chronic stressors may lead to an enhanced DA release following administration of many 
drugs of abuse.   
In conjunction with producing an enhancement of METH-induced DA, chronic 
stress or exposure to CORT may increase the METH-induced toxicity associated with 
DAT and other receptors. Animals exposed to 10 days of unpredictable stress and 
subsequently exposed to a neurotoxic regimen of METH showed enhanced extracellular 
striatal GLUT, increased long-term depletions in striatal DA and serotonin tissue 
concentrations, and decreased immunoreactivity of DAT and the serotonin transporter in 
the striatum (Matuszewich & Yamamoto, 2004b; Tata & Yamamoto, 2008); further, 
these effects appear to be mediated by the classical genomic effects of CORT as 
administration of the CORT synthesis inhibitor metyrapone prior to each stressor 
attenuated the combined effects of stress and METH.  CORT has previously been shown 
to increase non-stimulated (i.e. basal) levels of ROS in hippocampal explants (McIntosh 
& Sapolsky, 1996), suggesting that CORT could enhance METH-induced production of 
ROS.  Importantly, recent research has indicated that exposure to chronic CORT 
significantly enhanced METH-induced dopaminergic nerve terminal damage and 
neuroinflammation (Kelly, Miller, Bowyer, & O'Callaghan, 2012).  Collectively, these 
studies suggest that previous exposure to chronic CORT may enhance the amount of 
METH-stimulated DA and subsequently lead to increased oxidative stress and nerve 
terminal damage. 
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Stress, Methamphetamine and the NMDA Receptor 
 Given the evidence for interactions between stress, METH, and GLUT, it is 
surprising that few studies have been conducted on the subject.  One study showed that 
10 days of chronic, unpredictable stress resulted in increased METH-induced DA release 
and long-term depletions of DA neurons in the striatum, suggesting that stress may leave 
the brain more vulnerable to future excitotoxic insults such as psychostimulant exposure 
(Matuszewich & Yamamoto, 2004a).  Recently, it was shown that chronic unpredictable 
stress resulted in enhanced GLUT release in the hippocampus (Raudensky & Yamamoto, 
2007a) and in the striatum (Tata & Yamamoto, 2008) following a METH challenge. 
Further, the NMDA receptor is essential for neurochemical sensitization following 
repeated METH (Nakagawa et al., 2011), though no study has examined if this translates 
to repeated stress-induced neurochemical sensitization. Thus, the mechanism behind 
stress-induced vulnerability to enhanced toxicity produced by psychostimulant use and 
relapse may lay in the glutamatergic NMDA receptor.   
Experimental Rationale 
With no current pharmacological treatment for METH dependence (Chen, Wu, 
Zhang, & Hashimoto, 2010), it is of utmost importance to identify the mechanism by 
which METH causes toxicity and if that toxicity is exacerbated with continued stress.  
The mesocorticolimbic reward pathway appears to be critical in mediating the effects of 
both stress and drugs of abuse such as METH.  The current set of studies tested the 
involvement of the NMDA receptor in CORT-mediated changes in neuronal viability, 
NMDA receptor subunit levels, and DA/GLUT levels in response to an excitotoxic 
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challenge in an in vitro model of the DA reward pathway.  Experiment 1 tested the 
hypothesis that chronic CORT sensitizes the mesolimbic DA reward pathway to NMDA-
induced insults in a GR- and NMDA receptor-dependent manner, as evidenced by 
increased levels of propidium iodide (PI) uptake (as a measure of cell death/damage) and 
decreased levels of neuronal nuclear protein (NeuN; to detect healthy mature neurons) 
immunoreactivity.  Given that METH is a known excitotoxin, experiment 2A tested the 
hypothesis that chronic CORT exposure potentiates METH-induced neurotoxicity in a 
NMDA receptor-dependent manner, as evidenced by CORT+METH producing increased 
PI uptake and decreased levels of NeuN immunoreactivity.  Experiment 2B tested the 
hypothesis that chronic CORT and acute METH act synergistically to produce increased 
expression of the NR1 and NR2B NMDA receptor subunits.  Experiment 2C examined 
the hypothesis that antagonism of the NMDA receptor would prevent the CORT-induced 
potentiation of METH-evoked DA and GLUT overflow.  Levels of DA and GLUT were 
assessed using high-performance liquid chromatography (HPLC).   
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Chapter 2 
Methods – Experiment 1 
1.1 Organotypic Double Co-culture Preparation 
In vitro work is well suited to examine CORT-induced differences, as in vivo 
studies with rodents are confounded by diurnal fluctuations in CORT concentrations and 
in vitro models allow for precise control over CORT concentrations.  In addition, though 
the effects of in vitro aging on receptor density have not yet been examined in co-cultures 
of the NAcc and VTA, Martens and Wree (2001) noted that NMDA receptor distribution 
was comparable in hippocampal slices aged in vitro and those taken from aged-matched 
rats and previous studies have found that a number of synaptic components remain at a 
steady level following a brief initial depression (Bahr et al., 1995).  Additionally, 
numerous studies have investigated the use of long-term organotypic co-cultures of the 
VTA/NAcc and reported in tact morphology, re-innervation of dopaminergic tracts into 
the NAcc, and survival for up to 3 months (Jaumotte & Zigmond, 2005; Lyng, Snyder-
Keller, & Seegal, 2007; Ostergaard, Schou, & Zimmer, 1990).  Thus, organotypic cell 
culture studies allow for long-term and detailed manipulations investigating mechanisms 
of brain activity while minimizing environmental influences and may provide a better 
understanding of CORT-NMDA interactions in vivo.  Eight day old male and female 
Spraque-Dawley rats (Harlan Laboratories, Indianapolis, IN) were humanely sacrificed 
and the brains aseptically removed.  Following removal, brains were transferred to ice-
cold dissecting media (4°C), composed of Minimum Essential Medium (MEM; 
Invitrogen, Carlsbad, CA), 25 mM HEPES (Sigma, St. Louis, MO), and 50 µM 
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streptomycin/penicillin (Invitrogen).  Following aseptical removal, brains were sliced 
mid-sagitally and sectioned coronally at 400 µm thickness using a McIllwain Tissue 
Chopper (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK).  After sectioning, 
slices were placed into culture medium, containing dissecting medium along with 
distilled water, 36 mM glucose (Fisher, Pittsburg, PA), 25% (v/v) Hanks’ Balanced Salt 
Solution (HBSS; Invitrogen) and 25% heat-inactivated horse serum (HIHS; Sigma) and 
0.05% streptomycin/penicillin (Invitrogen).  Using a dissecting microscope, intact slices 
containing the NAcc and VTA were identified, yielding approximately 4-6 slices of each 
region per animal.  Two pair of co-cultures (each pair containing one NAcc and one VTA 
in slight contact) was plated onto Millicell-CM 0.4 µm biopore membrane inserts (Fisher) 
with 1 mL of pre-incubated culture media added to the bottom of each well of a six well 
plate.  The striatal slices also included a strip of pre-motor cortex that was not analyzed.  
Using the dissecting microscope, slices were oriented such that the NAcc and VTA were 
in slight contact with each other.  Plates were then incubated at 37°C with a gas 
composition of 5%CO2/95% air for 21 days to allow the co-cultures to grow together and 
attach to inserts.  During this time, the culture media was refreshed every 3 days.  Care of 
all animals was carried out in agreement with the University of Kentucky’s Institutional 
Animal Care and Use Committee as well as the National Institutes of Health Guide for 
the Care and Use of Laboratory Animals (NIH Publications No. 80-23).  
1.2 Characterization of Double Co-culture Model 
1.2a Autoradiography for Dopamine Transporter 
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Several measures were taken in order to better characterize the NAcc/VTA co-
cultures.   Autoradiography was conducted for qualification of dopamine transporter 
binding sites in control-treated cultures.  Following 21 days of continuous culture media 
exposure, co-cultures were flash-frozen in isopentane (Sigma) on dry ice and stored at -
80°C until [
125
I]RTI 55-940 binding studies were completed.  For [
125
I]RTI 55-940 
binding, the Teflon membranes on which the co-cultures were maintained were excised 
and secured onto glass slides.  The glass slides containing the co-cultures were then 
preincubated for 10 minutes in 50 mM Tris-HCl (Sigma) containing 3 mM MgCl2 
(Sigma), 0.2 mM ethylene glycol tetraacetic acid (Sigma), and 100 NaCl (Sigma) at room 
temperature.  Following preincubation, tissue was then incubated with [
125
I]RTI 55-940 
(0.01 nM) at room temperature for 120 minutes in the above Tris-HCl solution also 
containing 30 nM fluoxetine (Sigma).  After the 120 minute radioligand incubation 
period, cultures were washed with Tris-HCl wash buffer for 1 minute, followed by two 
20-minute wash periods, at 4°C.  Following washing, cultures were dipped in water at 
4°C and allowed to dry overnight.  Slides containing the cultures were then placed into a 
light-proof cassette and exposed to Kodak film (Fisher).  Films were developed following 
approximately 3 days of exposure.    
1.2b Immunohistochemistry of Tyrosine Hydroxylase and Myelin Basic Protein 
In addition to autoradiography, immunohistochemistry for tyrosine hydroxylase 
(the rate limiting enzyme in the synthesis of dopamine) and myelin basic protein (to stain 
myelinated axon fibers) was also conducted on control-treated co-cultures.  Following 21 
days of exposure to control media, co-cultures were fixed by transferring the insert 
containing the co-culture to a plate containing 1 mL of 10% formalin solution on the 
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bottom of each well.  One mL of formalin was also placed on top of the insert and the 
plates were allowed to sit for 30 minutes.  The slices were then washed carefully (1 mL 
on bottom of the well and 1 mL on top of the well) with 1 X phosphate buffered saline 
(PBS) twice and stored with 1 mL of 1 X PBS on the bottom of the well overnight at 4°C.  
Following overnight storage, the inserts were transferred to a plate containing 1 mL of 
membrane permeabilization buffer (200 mL 1 X PBS (Invitrogen), 200 µL Triton X-100 
(Sigma), 0.010 mg Bovine Serum (Sigma)) in each well and 1 mL of permeabilization 
buffer was also placed on top of each insert containing the slices.  The slices were 
allowed to sit in buffer for 45 minutes to allow the buffer to penetrate the slice and were 
then washed twice with 1 X PBS as described earlier.  Inserts were then transferred to a 
plate containing 1 mL of 1 X PBS on the bottom of each well and were treated with 1 mL 
of permeabilization buffer containing mouse anti-tyrosine hydroxylase (1:200; Sigma) 
and rabbit anti-myelin basic protein (MBP; 1:100; Sigma) on top of each well.  Plates 
were then stored at 4°C for 24 hours.  Following 24 hours, the slices were washed gently 
with 1 X PBS twice and were again transferred to a plate containing 1 mL of 1 X PBS on 
bottom.  At this point, slices were treated with 1 mL of permeabilization buffer 
containing the goat anti-mouse secondary antibody conjugated to fluorescein 
isothiocyanate (FITC; 1:100; Sigma) for tyrosine hydroxylase-labeled cultures and the 
goat anti-rabbit secondary antibody conjugated to tetramethylrhodamine isothiocyanate 
(TRITC; 1:200; Sigma) for myelin basic protein-labeled cultures on top of the insert and 
were stored at 4°C for 24 hours.  After 24 hours, slices were washed twice with 1 X PBS 
as described previously and placed into a plate containing 1 mL of 1 X PBS on the 
bottom of each well.  The slices were imaged immediately with PBS under each insert.  
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Co-cultures were visualized with SPOT advanced version 4.0.2 software for Windows 
(W. Nuhsbahm Inc.; McHenry, IL, USA) using a 2.5x objective with a Leica DMIRB 
microscope (W. Nuhsbahm Inc.; McHenry, IL, USA) fitted for fluorescence detection 
(mercury-arc lamp) using blue-green light and connected to a personal computer  through 
a SPOT 7.2 color mosaic camera (W. Nuhsburg).   The secondary antibody with FITC 
was elicited using a band-pass filter at 495 nm (520 nm emission) while the secondary 
antibody conjugated to TRITC was elicited using a band-pass filter that excites 
wavelengths between 515-560 nm (620 nm emission).   
1.3 CORT pre-exposure 
Male and female co-cultures (n=2/well) were continuously exposed to 
physiologically relevant corticosterone (CORT; 1 µM; Sigma) for 5 days beginning at 21 
days in vitro (DIV), followed by a 24 hour co-exposure to NMDA.  At 21 DIV, co-
cultures were randomly transferred to plates containing either 1 mL of culture media with 
0.2% dimethyl sulfoxide (DMSO: vehicle control; Fisher) or 1 mL of culture media 
containing 1 µM of CORT.  For studies investigating the potential role of the GR, a 
subset of these cultures was also exposed to the GR antagonist mifepristone (10 µM; 
Sigma) for 5 days beginning at 21 DIV.  For all experiments, CORT and mifepristone 
stock solutions were dissolved in 100% DMSO and diluted with culture media to the 
desired concentration so as to yield a final concentration of 0.2% DMSO.  Concentrations 
of CORT and mifepristone were chosen based on physiological relevance to exposure to 
a variety of stressors as well as previous organotypic experiments (Bielajew, Konkle, & 
Merali, 2002; Livezey, Miller, & Vogel, 1985; Mulholland, Self, Harris, Littleton, & 
Prendergast, 2004b; Sharrett-Field, Butler, Berry, Reynolds, & Prendergast, 2013).  All 
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six-well plates were then returned to an incubator maintained at 37°C with a gas 
composition of 5%CO2/95% air.  This exact treatment regimen was repeated at 24 DIV.   
1.4 NMDA co-exposure 
At 26 DIV co-cultures were transferred to new plates containing either 1 mL of 
culture media with CORT or vehicle (as previously described) or 1 mL of culture media 
with CORT/vehicle along with NMDA (200 µM; Sigma).  This concentration of NMDA 
was chosen based on previous reports suggesting that higher concentrations (>100 µM) 
are necessary for NMDA-induced cytotoxicity in co-cultures containing the VTA-NAcc 
pair (Maeda, Ibi, Shimazu, & Akaike, 1998).  To test the involvement of the NMDA 
receptor, a subset of cultures was also co-exposed to the NMDA receptor antagonist 2-
amino-7-phosphonovaleric acid (APV; 50 μM; Sigma), or NMDA+APV (as above).  For 
studies investigating the potential role of the GR, a second subset of co-cultures was also 
co-exposed to NMDA and the GR antagonist mifepristone (as described above).  In 
addition, all culture media contained propidium iodide (PI; 3.74 µM; Molecular Probes, 
Eugene, OR) in order to assess cytotoxicity.   
1.5a Cytotoxicity Assessment via Propidium Iodide 
Cytotoxicity (PI staining of neurons and glia with damaged membranes) was 
evaluated in all regions of the co-cultures using fluorescent microscopy.  Previous 
literature has demonstrated that PI reliably correlates with other measures of cell death, 
including flouro-jade staining for histology and the release of lactate dehydrogenase 
within the culture media (for a review, see Zimmer, Kristensen, Jakobsen, & Noraberg, 
2000).  Co-cultures were visualized with SPOT advanced version 4.0.2 software for 
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Windows (W. Nuhsbahm Inc.; McHenry, IL, USA) using a 2.5x objective with a Leica 
DMIRB microscope (W. Nuhsbahm Inc.; McHenry, IL, USA) fitted for fluorescence 
detection (mercury-arc lamp) using blue-green light and connected to a personal 
computer  through a SPOT 7.2 color mosaic camera (W. Nuhsburg).   PI has an emission 
wavelength of 620 nm in the visual range and a peak excitation wavelength of 536 nm 
and was excited using a band-pass filter that excites a range of wavelengths (510-560 
nm).  Densitometry using Image J software (National Institutes of Health, Bethesda, MD) 
was used to measure the intensity of the PI fluorescence.  A background measurement 
was also taken from the visual field surrounding each co-culture and was subsequently 
subtracted from the region measurements of each co-culture.  The intensity was measured 
in each of the two regions of interest: the NAcc and the VTA.  Within each region, 
measurements of PI uptake were converted to percent control for comparison across 
repetitions.   
1.5b Cytoxicity Assessment via Immunohistochemical Analysis of the Neuronal Nuclear 
Protein (NeuN)  
Following imaging for PI uptake, co-cultures were subsequently fixed to assess 
immunoreactivity of the neuronal nuclear protein (NeuN) according to methods detailed 
above in section 1.2b except that slices were incubated overnight with 1 mL of 
permeabilization buffer containing mouse anti-NeuN (1:200; Millipore, Billerica, MA) 
on top of each well.  Recently, NeuN has also been classified as Fox-3, a member of the 
Fox-1 family of splicing regulators for pre-mRNA (Kim, Adelstein, & Kawamoto, 2009).  
Following two washes with 1 X PBS as described above, slices were treated with 1 mL of 
permeabilization buffer containing the goat anti-mouse secondary antibody conjugated to 
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fluorescein isothiocyanate (FITC; 1:100; Sigma) on top of the insert and were stored at 
4°C for 24 hours.  After 24 hours, slices were washed twice with 1 X PBS as described 
previously and placed into a plate containing 1 mL of 1 X PBS on the bottom of each 
well.  The slices were imaged immediately with PBS under each insert.  The slices were 
visualized as described previously above; the secondary antibody with FITC was excited 
using a band-pass filter at 495 nm (520 nm emission).  Densitometry using Image J 
software (National Institutes of Health) was used to measure the intensity of the FITC 
fluorescence.  A background measurement of fluorescence was taken from the visual 
field surrounding each slice and was subsequently subtracted from the region 
measurement of each slice before analysis.  The intensity was measured in each of the 
two regions of interest: the ventral tegmental area and the nucleus accumbens.  To control 
for the variability between each replication, measurements of FITC immunoreactivity 
were converted to percent control for each region before statistical analysis.   
1.6 Statistical Analysis 
Each well contained two co-cultures and each co-culture was analyzed 
individually. All treatment effects were examined using a two-way analysis of variance 
(ANOVA; treatment X sex).  Each experiment was conducted a minimum of 3 times 
using different rat litters, with each experimental condition containing 4 co-cultures.  A 
total of 8 different rat litters were used for these experiments, totaling a range of 4-16 
slices per sex per treatment group. Data from each replication was converted into percent 
control values and was subsequently combined if litter effects were absent.  When 
appropriate, post-hoc tests were conducted using Fisher’s LSD to examine further effects.  
Statistical significance was set at p<0.05.   
35 
 
Methods – Experiment 2 
2.1 Organotypic Triple Co-culture Preparation 
In vitro work is acutely suited to examine CORT-induced differences, as in vivo 
studies with rodents are confounded by diurnal fluctuations in CORT concentrations. In 
addition, though the effects of in vitro aging on receptor density have not yet been 
examined in triple co-cultures, Martens and Wree (2001) showed that NMDA receptor 
distribution was comparable in hippocampal slices aged in vitro and those taken from 
aged-matched rats.  Previous studies have found that a number of synaptic components 
remain at a steady level following a brief initial depression (Bahr, et al., 1995).  
Additionally, numerous studies have investigated the use of long-term organotypic co-
cultures of the VTA/NAcc and reported in tact morphology, re-innervation of 
dopaminergic tracts into the NAcc, and survival for up to 3 months (Jaumotte & 
Zigmond, 2005; Lyng, et al., 2007; Ostergaard, et al., 1990).  Thus, organotypic cell 
culture studies allow for long-term and detailed manipulations investigating mechanisms 
of brain activity while minimizing environmental influences and may provide a better 
understanding of CORT-METH interactions in vivo.  Eight day old male and female 
Spraque-Dawley rats (Harlan Laboratories, Indianapolis, IN) were humanely sacrificed 
and the brains aseptically removed. Following removal, brains were transferred to ice-
cold dissecting media (4°C), composed of Minimum Essential Medium (MEM; 
Invitrogen, Carlsbad, CA), 25 mM HEPES (Sigma, St. Louis, MO), and 50 µM 
streptomycin/penicillin (Invitrogen). Following aseptic removal, the brains were sliced 
mid-sagitally and subsequently sectioned coronally at 400 µm thickness using a 
McIllwain Tissue Chopper (Mickle Laboratory Engineering Co. Ltd., Gomshall, UK). 
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After sectioning, slices were placed into culture medium, containing dissecting medium 
along with distilled water, 36 mM glucose (Fisher, Pittsburg, PA), 25% (v/v) Hanks’ 
Balanced Salt Solution (HBSS; Invitrogen) and 25% heat-inactivated horse serum (HIHS; 
Sigma) and 0.05% streptomycin/penicillin (Invitrogen). Using a dissecting microscope, 
intact slices containing the NAcc, VTA, or mPFC were identified. Co-cultures containing 
one slice from each NAcc, VTA, and mPFC were plated onto Millicell-CM 0.4 µm 
biopore membrane inserts with 1 mL of pre-incubated culture media added to the bottom 
of each well of a six well plate. Using the dissecting microscope, slices were oriented 
such that the NAcc, VTA, and mPFC are in slight contact with each other (Figure 1A). 
Plates were then incubated at 37°C with a gas composition of 5%CO2/95% air for 21 
days to allow the triple slice co-cultures to grow and attach to inserts. During this time, 
the culture media was changed every 3 days. Care of all animals was carried out in 
agreement with the University of Kentucky’s Institutional Animal Care and Use 
Committee as well as the National Institutes of Health Guide for the Care and Use of 
Laboratory Animals (NIH Publications No. 80-23).   
2.2 Characterization of triple co-culture model 
2.2a Immunoreactivity of myelin basic protein 
In order to better characterize the triple slice co-cultures, immunohistochemistry 
for myelin basic protein (to stain myelinated axon fibers) was conducted on control-
treated co-cultures.  Following 21 days of exposure to control media, co-cultures were 
fixed by transferring the insert containing the co-culture to a plate containing 1 mL of 
10% formalin solution on the bottom of each well.  One mL of formalin was also placed 
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on top of the insert and the plates were allowed to sit for 30 minutes.  The slices were 
then washed carefully (1 mL on bottom of the well and 1 mL on top of the well) with 1 X 
phosphate buffered saline (PBS) twice and stored with 1 mL of 1 X PBS on the bottom of 
the well overnight at 4°C.  Following overnight storage, the inserts were transferred to a 
plate containing 1 mL of membrane permeabilization buffer (200 mL 1 X PBS 
(Invitrogen), 200 µL Triton X-100 (Sigma), 0.010 mg Bovine Serum (Sigma)) in each 
well and 1 mL of permeabilization buffer was also placed on top of each insert containing 
the slices.  The slices were allowed to sit in buffer for 45 minutes to allow the buffer to 
penetrate the slice and were then washed twice with 1 X PBS as described earlier.  Inserts 
were then transferred to a plate containing 1 mL of 1 X PBS on the bottom of each well 
and were treated with 1 mL of permeabilization buffer containing rabbit anti-myelin basic 
protein (1:100; Sigma) on top of each well.  Plates were then stored at 4°C for 24 hours.  
Following 24 hours, the slices were washed gently with 1 X PBS twice and were again 
transferred to a plate containing 1 mL of 1 X PBS on bottom.  At this point, slices were 
treated with 1 mL of permeabilization buffer containing the goat anti-rabbit secondary 
antibody conjugated to fluorescein isothiocyanate (FITC; 1:100; Sigma) for myelin basic 
protein-labeled cultures on top of the insert and were stored at 4°C for 24 hours.  After 24 
hours, slices were washed twice with 1 X PBS as described previously and placed into a 
plate containing 1 mL of 1 X PBS on the bottom of each well.  The slices were imaged 
immediately with PBS under each insert.  Co-cultures were visualized with SPOT 
advanced version 4.0.2 software for Windows (W. Nuhsbahm Inc.; McHenry, IL, USA) 
using a 2.5x objective with a Leica DMIRB microscope (W. Nuhsbahm Inc.; McHenry, 
IL, USA) fitted for fluorescence detection (mercury-arc lamp) using blue-green light and 
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connected to a personal computer  through a SPOT 7.2 color mosaic camera (W. 
Nuhsburg).   The secondary antibody with FITC was elicited using a band-pass filter at 
495 nm (520 nm emission). 
2.2b NMDA-induced Cytotoxicity via Propidium Iodide Uptake 
Following 21 days of exposure to control culture media, co-cultures were treated 
with culture media containing propidium iodide (PI) and the GLUT agonist NMDA (200 
μM).  PI staining of neurons and glia with damaged membranes was evaluated 24 hours 
later using fluorescent microscopy.  It has been shown previously that PI reliably 
correlates with other measures of cell death, including flouro-jade staining for histology 
and the release of lactate dehydrogenase within the culture media (for a review, see 
Zimmer, et al., 2000).  Co-cultures were visualized with SPOT advanced version 4.0.2 
software for Windows (W. Nuhsbahm Inc.; McHenry, IL, USA) using a 2.5x objective 
with a Leica DMIRB microscope (W. Nuhsbahm Inc.; McHenry, IL, USA) fitted for 
fluorescence detection (mercury-arc lamp) using blue-green light and connected to a 
personal computer  through a SPOT 7.2 color mosaic camera (W. Nuhsburg).   PI has an 
emission wavelength of 620 nm in the visual range and a peak excitation wavelength of 
536 nm and was excited using a band-pass filter that excites a range of wavelengths (510-
560 nm).   
2.3 CORT Pre-exposure in Co-cultures 
Male and female triple slice co-cultures (n=2/well) were continuously pre-
exposed to CORT for 5 days beginning at 21 days in vitro (DIV). At that time, co-
cultures were randomly transferred to plates containing either culture media with 0.1% 
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DMSO (vehicle control) or culture media containing CORT (1 µM) dissolved in 0.1% 
DMSO. Plates were then returned to an incubator maintained at 37°C with a gas 
composition of 5%CO2/95% air. This treatment was repeated at 24 DIV for a total of 5 
day pre-exposure to CORT.   
2.4 METH Exposure in Co-cultures 
Male and female triple slice co-cultures (n=2/well) were continuously pre-
exposed to CORT for 5 days beginning at 21 DIV. At 26 DIV, co-cultures were co-
exposed to CORT/vehicle and METH (0 or 100 μM; Sigma) in the presence or absence of 
the NMDA receptor antagonist 2-amino-7-phosphonovaleric acid (APV; 50 μM).  
Concentrations of CORT and METH were chosen for their relevance to stress and METH 
toxicity studies (Aizenman, McCord, Saadi, Hartnett, & He, 2010; Prendergast & 
Mulholland, 2012; Smith, et al., 2007).  Neuronal viability was quantified using PI or 
NeuN immunoreactivity (experiment 2A; 27-30 DIV) and NMDA receptor subunits were 
quantified using immunoblotting (experiment 2B) after 24 hour co-exposure to CORT 
and METH.   Additionally, 1 mL of aCSF was placed on top of each insert at the time of 
the acute METH treatment and collected 45 minutes later for evaluation of DA and 
GLUT content via HPLC (experiment 2C).   
2.5a Cytotoxicity assessment via Propidium Iodide 
Cytotoxicity (PI staining of neurons and glia with damaged membranes) was 
evaluated in all regions of the co-cultures using fluorescent microscopy.  It has been 
shown previously that PI reliably correlates with other measures of cell death, including 
flouro-jade staining for histology and the release of lactate dehydrogenase within the 
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culture media (for a review, see Zimmer, et al., 2000).  Co-cultures were visualized with 
SPOT advanced version 4.0.2 software for Windows (W. Nuhsbahm Inc.; McHenry, IL, 
USA) using a 2.5x objective with a Leica DMIRB microscope (W. Nuhsbahm Inc.; 
McHenry, IL, USA) fitted for fluorescence detection (mercury-arc lamp) using blue-
green light and connected to a personal computer  through a SPOT 7.2 color mosaic 
camera (W. Nuhsburg).   PI has an emission wavelength of 620 nm in the visual range 
and a peak excitation wavelength of 536 nm and was excited using a band-pass filter that 
excites a range of wavelengths (510-560 nm).  Densitometry using Image J software 
(National Institutes of Health, Bethesda, MD) was used to measure the intensity of the PI 
fluorescence.  A background measurement was taken from the visual field surrounding 
each co-culture and was subsequently subtracted from the regional measurements of each 
co-culture.  The intensity was measured in each of the three regions of interest: the NAcc, 
the VTA, and the mPFC.  Within each region, measurements of PI uptake were converted 
to percent control for comparison across repetitions.  To ensure reliability of PI as a 
measure of cytotoxicity, NeuN immunoreactivity was also examined as a marker of 
healthy mature neurons. 
2.5b Cytotoxicity Assessment via Immunohistochemical Analysis of the Neuronal Nuclear 
Protein 
Immunohistochemistry was conducted on CORT-naïve, CORT-exposed, METH-
naïve, and METH-exposed co-cultures to identify any CORT- or METH-induced changes 
in NeuN immunoreactivity. Following cytotoxicity analysis, co-cultures were transferred 
to a plate containing 1 mL of 10% formalin solution on the bottom of each well. One mL 
of formalin was also placed on top of the insert and the plates were allowed to sit for 30 
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minutes.  The co-cultures were then twice washed carefully (1 mL on bottom of the well 
and 1 mL on top of the well) with 1 X PBS and stored with 1 mL of 1 X PBS on the 
bottom of the well overnight at 4°C.  Following overnight storage, the inserts were 
transferred to a plate containing 1 mL of wash buffer (200 mL PBS [Invitrogen], 200 µL 
Triton X-100 [Sigma], 0.010 mg Bovine Serum [Sigma]) in each well, 1 mL of wash 
buffer was also placed on top of each insert containing the slices.  The co-cultures were 
allowed to sit in buffer for 45 minutes, allowing the buffer to penetrate the slice, and were 
then washed twice with 1 X PBS as described earlier.  Inserts were transferred to a plate 
containing 1 mL of 1 X PBS on the bottom of each well and were treated with mouse 
anti-NeuN antibody (1:200; Millipore) on top of each well.  Plates were stored at 4°C for 
24 hours.  Following 24 hour incubation with the primary antibody, the slices were 
washed gently with 1 X PBS twice and were again transferred to a plate containing 1 mL 
of 1 X PBS on bottom.  At this point, slices were treated with 1 mL of buffer containing 
the goat anti-mouse secondary antibody conjugated to fluorescein isothiocyanate (FITC; 
1:100; Sigma) on top of the insert and were stored at 4°C for 24 hours.  A range of 
concentrations was previously examined and the concentrations of NeuN and FITC 
antibodies chosen were shown to have the least amount of background while still 
maintaining specificity.  After a 24 hour incubation period with the secondary antibody, 
slices were washed twice with 1 X PBS as described previously and placed into a plate 
containing 1 mL of PBS on the bottom of each well.  The slices were then imaged 
immediately according to the method below. 
The immunofluorescence of each co-culture was visualized as described above 
(see cytotoxicity assessment) except that the secondary antibodies with FITC was excited 
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using a band-pass filter at 495 nm (FITC; 520 nm emission).  Densitometry using Image J 
software was again used to measure the intensity of the fluorescence.  A background 
measurement of non-specific fluorescence was taken from the visual field surrounding 
each co-culture and was subsequently subtracted from the region measurement of each 
area of interest before analysis.  The intensity was measured in each of the three regions 
of interest: the NAcc, the VTA, and the mPFC.  To control for the variability between 
each replication, measurements of NeuN immunoreactivity were converted to percent 
control for each region before statistical analysis.   
2.6 Western Blot Procedure 
While immunohistochemistry has the advantage of investigating regional 
differences, the thickness of the co-cultures (400 µm) may affect the ability of 
densitometry to detect subtle differences.  Thus, a subset of male and female control, 
CORT-, and METH-exposed co-cultures were used in immunoblotting analysis.  Co-
cultures were homogenized in ice-cold lysis buffer containing 62.5 mM trimethylol 
aminomethane (Fisher), 6 M urea (Sigma), 10% glycerol (Fisher), and 2% sodium 
dodecyl sulfate (SDS; Sigma) with an adjusted pH of 6.8.  Prior to tissue collection, 1 ml 
of PMSF (phenylmethanesulfonylfluoride; Sigma) + PBS solution was placed on the 
bottom of each well in an empty 6 well plate.  Stock PMSF (99.8 µM) was first dissolved 
in 200 proof EtOH and diluted to yield a final concentration of 1:100 (PMSF: 1 X PBS).  
A protease inhibitor cocktail tablet (Sigma) was added to 0.5 mL lysis buffer and further 
diluted to a concentration of 1:100 using lysis buffer (v/v).  Inserts were then transferred 
to the plate containing PMSF+PBS and 100 µL of the lysis buffer-protease inhibitor 
mixture was then placed on top of each well.  Tissue was subsequently scraped from the 
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teflon membrane and placed into 1.5 mL microcentrifuge tubes.  The tissue was sonicated 
for 10-15 seconds at 20% amplitude (Sonics and Materials, Newtown, CT), immediately 
aliquoted for storage at -80°C until use.  A 10 µL aliquot was used to determine the 
amount of protein within each sample using the Pierce BCA protein assay kit (Fisher). 
Based on the results from the protein assay, equal amounts of protein (20 µg) 
were compared against molecular weight standards (Bio-Rad, Hercules, CA) on 10-lane 
4-15% tris-glycine polyacrylamide gels (Bio-Rad).  Samples were electrophoresed on ice 
for 60 minutes at 150 V using the mini-PROTEAN tetra system (Bio-Rad) in 1 X 
tris/glycine/SDS buffer (Bio-Rad).  Following electrophoresis, gels were removed 
carriages and allowed to soak in transfer buffer (1 X tris/glycine/SDS buffer + 20% 
methanol) for 5 minutes.  Samples were then transferred to 0.45 µM nitrocellulose 
membrane paper (Bio-Rad) at 100 V for 60 minutes at room temperature in the presence 
of an ice pack using the mini-PROTEAN tetra system.  Following transfer to the 
nitrocellulose paper, membranes were then washed in 1 X TBS (Bio-Rad) for 15 minutes 
at room temperature prior to placement in a blocking solution of 5% nonfat dry milk 
powder in 1 X TBS for 60 minutes at room temperature.  Membranes were then rinsed in 
TTBS (1 X TBS + 0.05% Tween 20 [Fisher]) for 15 minutes at room temperature and 
subsequently incubated with primary antibodies (mouse anti-NR1, 1:1000, BD 
Biosciences PharMingen; rabbit anti-NR2B, 1:1000, Millipore) overnight at 4°C with 
agitation in a 5% nonfat dry milk powder and TTBS solution.  On the second day, 
membranes were washed for 20 minutes in TTBS and then incubated with the species-
appropriate fluorescent secondary antibodies (1:5000, Rockland Immunohistochemincals, 
Gilbertsville, PA) in light-proof boxes at room temperature for 1 hour with agitation.  
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Membranes were then washed again for 20 minutes in TTBS and then scanned and 
quantified using an Odyssey infrared imaging system (Li-Cor Biosciences, Lincoln, NE).  
Fluorescent intensity was again determined using Image J software and was converted to 
percent control to compare across treatment groups.  This protocol was modified from the 
laboratories of Dr. James Geddes and Dr. Patrick Mulholland. 
2.7 High Performance Liquid Chromatography for Dopamine and Glutamate 
Artificial cerebrospinal fluid samples were analyzed for DA and GLUT content 
using HPLC with electrochemical detection (HPLC-EC, ESA Inc., Chelmsford, MA). 
The DA HPLC system consisted of a solvent delivery unit, a Coulochem III 
electrochemical detector equipped with a 5014B analytical cell, and a 5020 guard cell.  
For DA analysis, the guard cell was set at +350 mV, electrode 1 at -150 mV, and 
electrode 2 at +220 mV with the gain set to 10 nA. The DA mobile phase consisted of 75 
mM NaH2PO4, 1.7 nM 1-octanesulfonic acid, 24 μM ethylenediaminetetraacetic acid, 
100 μl/L triethylamine and 10.7% acetonitrile (pH was adjusted to 3.0 with phosphoric 
acid), and was pumped through the system at 0.5 mL/minute.  Samples (20 µL) for DA 
analysis were loaded into a 100 μL loop and injected onto an analytical column (MD-150 
3.2mm x 100mm, 3um Dionex, ThermoScientific, Sunnyvale, CA).  The GLUT HPLC 
system consisted of a solvent delivery unit, a Coulochem III electrochemical detector 
equipped with a 5011 analytical cell, and a 5020 guard cell. For GLUT analysis, the 
guard cell was set at +650 mV, electrode 1 at +150 mV, electrode 2 at +550 mV, and the 
gain was set at 5 μA.  Precolumn derivatization of GLUT with ο-phthaldialdehyde (OPA; 
Pickering Lab Inc, CA) and 2-mercaptoethanol (Sigma) was performed using an ESA 
542 autosampler.  The GLUT mobile phase consisted of 100 mM Na2HPO4, 16% 
45 
 
methanol, and 2.5% acetonitrile (pH was adjusted to 6.5 with phosphoric acid), and was 
pumped through the system at 0.5 mL/minute.  GLUT and aspartate were separated using 
an analytical column (Xterra MS C18 2.5 um 3.0 x 50mm column, Waters, Milford, 
MA).  Retention times of external standards were used to determine the corresponding 
peak height of both DA and GLUT.  Chromatograms of samples were then compared 
against the external standards using an ESA Chromatography Data System (EZChrom 
Elite, Chelmsford, MA).  HPLC analysis was conducted with assistance from the 
laboratory of Dr. Michael Bardo at the University of Kentucky. 
2.8 Statistical Analysis 
Each triple slice co-culture was analyzed individually.  To test for treatment and 
sex differences for experiment 1, a two-way analysis of variance (ANOVA; treatment x 
sex) was investigated for each region of interest: NAcc, VTA, and mPFC.  Investigations 
from experiments 2 and 3 implemented a one-way ANOVA for treatment for western 
blot and HPLC analysis.  Each experiment was conducted a minimum of 3 times using 
different rat litters. Data from each replication were converted into percent control values 
and subsequently combined if litter effects were absent.  When appropriate, post-hoc tests 
were conducted using Fisher’s LSD to examine further effects.  Statistical significance 
was set at p<0.05.   
 
 
 
Copyright © Jennifer Nicole Berry 2013  
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CHAPTER 3 
Results – Experiment 1 
Characterization of Double Co-culture Model (Figure 1.1) 
Co-cultures of the NAcc and VTA were plated such that the two regions were 
touching with juncture points at the mid-ventral surface of each culture and allowed to 
culture for 21 days in vitro. Initial studies were completed to characterize the NAcc/VTA 
co-culture model and possible re-innervation of dopaminergic phenotypes.  Figure 1.1A 
illustrates a light microscope picture indicating the orientation of both the NAcc and 
VTA as well as the junction of the co-cultures.  Densely labeled autoradiography of the 
dopamine transporter using 125I-RTI-55 binding (Figure 1.1B) was observed in the region 
bridging the co-cultures.  In addition, immunoreactivity of tyrosine hydroxylase (Figure 
1.1C; the rate limiting enzyme in the synthesis of catecholamines) and myelin basic 
protein (Figure 1.1C; to stain myelinated fibers) was also examined with concentrated 
staining in the region bridging the junction of the co-cultures.  Taken together, these 
results suggest re-innervation within the co-culture model that is likely dopaminergic in 
nature.  
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Figure 1.1. Organotypic midbrain-striatal co-cultured ex vivo with ventral tegmental area 
and nucleus accumbens in contact (2.5x magnification).  A. bright-field image of co-
cultures; B. Autoradiographic localization of 
125
I-RTI-55 binding (dopamine transporter) 
and point of juncture; C. merged image of tyrosine hydroxylase (FITC; green) and myelin 
basic protein (TRITC; red) immunoreactivity at point of juncture.  
C 
A 
B 
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Effects of CORT on NMDA-induced Cytotoxicity via Propidium Iodide Uptake (Figures 
1.2 and 1.3; Table 1.1) 
This set of experiments was designed to assess the neurotoxic effects of 5 days of 
previous CORT pre-exposure followed by 24 hours of co-exposure to CORT and 
NMDA, and to investigate the potential roles of the NMDA receptor and the GR in the 
observed cytotoxicity.  There was no difference in toxicity between sexes within each 
treatment group, and male and female data were combined for further analysis.  Thus, a 
one-way ANOVA for treatment was conducted within each region of interest.  In the 
VTA, a significant main effect of treatment was observed (Figure 1.2; F(11, 198)=4.277, 
p<0.001).  Regardless of acute treatment (NMDA/APV/mifepristone), vehicle-pretreated 
co-cultures showed no significant toxicity in the VTA (~95-130% vehicle control; Figure 
1.2A).  Further, exposure to continuous CORT (for a total of 6 days) in NMDA-naïve 
tissue produced no significant changes in toxicity compared to vehicle treated co-cultures 
(~95 % vehicle control; Figure 1.2B).  However, significant toxicity was observed in the 
VTA after 5 days of pre-exposure to CORT followed by 24 hour exposure to 
CORT+NMDA (~170% vehicle control; Fisher’s LSD post-hoc, p<0.001).  The NMDA-
induced toxicity in CORT pre-treated co-cultures was significantly attenuated by co-
exposure to APV (p<0.001).  In regards to the GR, pre-treatment with mifepristone 
during the 5 day exposure to CORT prior to the 24 hour co-exposure to NMDA 
significantly reduced CORT+NMDA toxicity (p<0.01).  Thus, chronic CORT pre-
exposure sensitized the VTA to subsequent NMDA receptor-dependent toxicity, and this 
effect was also dependent on activation of the GR during the CORT pre-exposure.  
Representative images of these effects are presented in Figure 1.3. 
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Within the NAcc, a significant main effect of treatment was observed (table 1.1; 
F(11, 198)=4.783, p<0.001).  Compared to vehicle alone, 5 days of pre-exposure to either 
vehicle or CORT in the presence of mifepristone significantly enhanced subsequent 
NMDA-induced toxicity produced by the 24 hour co-exposure to 200 μM NMDA 
(~130% vehicle control; p<0.05).  Exposure to CORT (for a total of 6 days) in NMDA-
naïve tissue produced no significant changes in toxicity compared to vehicle treated co-
cultures (~96 % vehicle control).  However, in contrast to the effects seen within the 
VTA, there was no significant toxicity observed in co-cultures pre-treated with CORT 
and later co-exposed to NMDA (~97% vehicle control).  Representative images of these 
effects are presented in Figure 1.3. 
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Figure 1.2. Effects of 5 day pre-treatment with either vehicle (DMSO; panel A), 1 µM 
CORT (panel B), 10 µM mifepristone, or CORT + mifepristone prior to 24 hour co-
exposure to either vehicle/CORT/mifepristone along with 200 µM NMDA + 50 µM APV 
on PI uptake within the ventral tegmental area (VTA).  Pre-treatment with CORT prior to 
NMDA exposure resulted in significant neurotoxicity, an effect which was not seen in 
vehicle pre-treated cultures.  Co-exposure to the competitive NMDA receptor antagonist 
APV prevented the NMDA-induced cytotoxicity in CORT pre-treated cultures.  Co-
exposure to the glucocorticoid receptor antagonist mifepristone during the 5 day CORT 
pre-treatment and subsequent NMDA exposure also significantly attenuated the ability of 
CORT to potentiate NMDA-induced toxicity.  Dashed line represents DMSO-treated 
value. Data represented as percentage of DMSO-treated cultures (mean ± SEM).* p<0.05 
vs. DMSO (vehicle) levels; # p<0.05 vs. DMSO+NMDA, 
CORT+MIFEPRISTONE+NMDA, CORT+NMDA+APV  
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Figure 1.3. Representative images of PI uptake in co-cultures of the NAcc and VTA 
pretreated with either DMSO, CORT, DMSO + mifepristone, or CORT + mifepristone 
and exposed to NMDA or NMDA + APV for 24 hours. 
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PI Uptake NAcc mean ± SEM 
DMSO     99.998 ± 4.960 
DMSO + mifepristone   116.247 ± 6.567 
DMSO + APV    98.734 ±4.197 
DMSO + NMDA     90.558 ± 4.313 
DMSO + mifepristone + NMDA *120.767 ± 2.996 
DMSO + NMDA + APV   112.903 ± 6.842 
CORT    95.542 ±3.716 
CORT + mifepristone  118.572 ±6.377 
CORT + APV  108.853 ±5.760 
CORT + NMDA     96.700 ± 4.771 
CORT + mifepristone + NMDA *134.002 ± 3.754 
CORT + NMDA + APV       99.648 ± 11.851 
 
 
 
Table 1.1. Effects of 5 day pre-treatment with either vehicle (DMSO), 1 µM CORT, 10 
µM mifepristone, or CORT + mifepristone prior to 24 hour co-exposure to either 
vehicle/CORT/mifepristone + 200 µM NMDA + 50 µM APV on PI uptake within the 
nucleus accumbens (NAcc).  Co-exposure to the glucocorticoid receptor antagonist 
mifepristone during the 5 day pre-treatment and subsequent NMDA exposure resulted in 
significant toxicity within the NAcc, while pre-treatment with CORT in the absence of 
mifepristone had no effect on NMDA-induced neuronal toxicity. * p<0.05 vs. DMSO 
(vehicle) levels 
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Effects of CORT on NMDA-induced loss of NeuN Immunoreactivity (Figures 1.4 and 1.5; 
Table 1.2) 
This set of experiments also sought to determine the effects of 5 days of previous 
CORT pre-exposure followed by 24 hours of co-exposure to CORT and NMDA and/or 
the competitive NMDA receptor antagonist APV on NeuN immunoreactivity. There was 
again no difference in immunoreactivity for NeuN between sexes within each treatment 
group, and male and female data were combined for further analysis.  Thus, a one-way 
ANOVA for treatment was conducted within each region of interest.  In the VTA, a 
significant main effect of treatment was observed (Figure 1.4; F(11, 90)=3.172, p<0.001). 
Regardless of acute treatment (NMDA/APV/mifepristone), vehicle-pretreated co-cultures 
showed no significant loss of NeuN immunoreactivity within the VTA (~90-100% 
vehicle control; Figure 1.4A).  Additionally, exposure to continuous CORT (for a total of 
6 days) in NMDA-naïve tissue produced no significant changes in the density of NeuN 
compared to vehicle treated co-cultures (~84% vehicle control; p>0.05; Figure 1.4B).  In 
agreement with PI data described above, a significant loss of NeuN immunoreactivity 
was observed in the VTA after 5 days of pre-exposure to CORT, but not vehicle, 
followed by 24 hour exposure to CORT+NMDA (~80% vehicle control; p<0.01).  
Further, the CORT+NMDA-induced loss of NeuN was dependent on the NMDA 
receptor, as co-exposure to the NMDA receptor antagonist APV attenuated this loss 
(~93% vehicle control; p<0.05).  In regards to the GR, pre-treatment with mifepristone 
during the 5 day exposure to CORT prior to the 24 hour co-exposure to NMDA 
significantly attenuated the CORT+NMDA-induced loss of NeuN (~95% vehicle control; 
p<0.01).  Thus, within the VTA, chronic CORT pre-exposure followed by acute NMDA 
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exposure produced significant losses in NeuN immunoreactivity that was dependent on 
both NMDA receptor- and GR-activation.  Representative images of these effects are 
presented in Figure 1.5.  In contrast to the VTA, no significant main effects of treatment 
nor interactions were found in the NAcc region (table 1.2).   
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Figure 1.4. Effects of 5 day pre-treatment with either vehicle (DMSO; panel A), 1 µM 
CORT (panel B), 10 µM mifepristone, or CORT + mifepristone prior to 24 hour co-
exposure to either vehicle/CORT/mifepristone along with 200 µM NMDA + 50 µM APV 
on immunoreactivity of the neuronal nuclear protein (NeuN) within the ventral tegmental 
area (VTA).  Pre-treatment with CORT prior to NMDA exposure resulted in a significant 
loss of NeuN immunoreactivity, an effect which was not seen in vehicle pretreated 
cultures.  Co-exposure to either the competitive NMDA receptor antagonist APV (during 
NMDA exposure) or to the glucocorticoid receptor antagonist mifepristone (during the 5 
day CORT pre-treatment and subsequent NMDA exposure) significantly attenuated the 
ability of CORT to potentiate NMDA-induced toxicity.  Dashed line represents DMSO-
treated value. Data represented as percentage of DMSO-treated cultures (mean ± SEM). * 
p<0.05 vs. DMSO (vehicle) levels; # p<0.05 vs. DMSO+NMDA, 
CORT+MIFEPRISTONE+NMDA, CORT+NMDA+APV. 
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Figure 1.5.  Representative images of NeuN immunoreactivity in co-cultures of the 
NAcc and VTA pretreated with either DMSO, CORT, DMSO + mifepristone, or CORT 
+ mifepristone and exposed to NMDA or NMDA + APV for 24 hours. 
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NeuN Immunoreactivity NAcc mean ± SEM 
DMSO    100.000 ±2.908 
DMSO + mifepristone 92.565 ±6.041 
DMSO + APV 98.543 ±5.006 
DMSO + NMDA    102.821 ±1.592 
DMSO + mifepristone + NMDA 89.571 ±4.678 
DMSO + NMDA + APV 105.567 ±14.182 
CORT 91.295 ±4.121 
CORT + mifepristone 93.203 ±3.120 
CORT + APV 89.989 ±5.601 
CORT + NMDA 81.590 ±4.091 
CORT + mifepristone + NMDA 95.285 ±3.055 
CORT + NMDA + APV 92.746 ±4.959 
 
 
Table 1.2. Effects of 5 day pre-treatment with either vehicle (DMSO), 1 µM CORT, 10 
µM mifepristone, or CORT + mifepristone prior to 24 hour co-exposure to either 
vehicle/CORT/mifepristone + 200 µM NMDA + 50 µM APV on neuronal nuclear 
protein (NeuN) immunoreactivity within the nucleus accumbens (NAcc).  No statistically 
significant changes were observed in immunoreactivity for NeuN. 
 
  
58 
 
Results – Experiment 2 
Characterization of Triple Co-culture Model (Figure 2.1) 
Several measures have also examined the validity of the triple co-culture model 
containing the VTA, NAcc, and PFC.  Figure 2.1A (far top) shows a light microscopy 
picture of a control-treated co-culture, indicating the regions of interest and placement of 
each region so as to mimic the in vivo pathway.  Further, immunoreactivity of MBP in 
control-treated co-cultures has been examined (Figure 2.1B; with the arrow indicating 
concentrated myelinated fibers at the junction of the co-cultures).  Figure 2.1C (bottom) 
shows PI staining for neuronal toxicity following 24 hour exposure to 200 μM NMDA in 
co-cultures, indicating the viability of all 3 regions of interest.  These preliminary data 
indicate the neuronal viability and re-connectivity in triple slice co-cultures containing 
the VTA, NAcc, and PFC.  
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Figure 2.1. Triple slice co-cultures of VTA, NAcc, and mPFC. Top (A): Bright-field 
image of organotypic co-cultures containing the VTA, NAcc, and PFC showing the 
orientation of the co-culture, with the ventral striatum in contact with the VTA and the 
dorsal striatum in contact with the mPFC. Middle (B): Immunoreactivity of MBP in 
triple slice co-culture, with arrow indicating the junction of co-cultures. Bottom (C): 
image showing propidium iodide uptake following 24 hour exposure to NMDA (200 
µM), indicating NMDA-induced toxicity.  
NAcc 
VTA 
PFC 
C 
A 
B 
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Effects of CORT on METH-induced PI Uptake (Figures 2.2 and 2.3) 
This experiment was designed to assess the neurotoxic effects of 5 days of 
previous CORT pre-exposure followed by 24 hours of co-exposure to CORT and METH, 
and to investigate the potential role of the NMDA receptor in the observed cytotoxicity.  
There was no difference in toxicity between sexes within each treatment group, and male 
and female data were combined for further analysis.  Thus, a one-way ANOVA for 
treatment was conducted within each region of interest.  In the mPFC, a significant main 
effect of treatment was observed (Figure 2.2A; F(7, 102)=5.325, p<0.001).  Five day pre-
exposure to CORT followed by 24 hour co-exposure to CORT and METH resulted in 
significant toxicity in the mPFC compared to vehicle-pretreated co-cultures (~140% 
vehicle control; Fisher’s LSD post-hoc, p<0.001).  Further, neither CORT alone nor 
vehicle + METH produced significant toxicity in this region.  The observed CORT and 
METH-induced toxicity within the mPFC was significantly attenuated by co-exposure to 
the NMDA receptor antagonist APV during the 24 hour co-exposure period (p<0.01).  
Within the NAcc, no significant main effects were observed (Figure 2.2B; F(7, 
102)=2.001, p=0.062).  In the VTA region, a significant main effect of treatment was 
observed (Figure 2.2C; F(7, 102)=3.428, p<0.01).   Compared to vehicle-treated co-
cultures, exposure to CORT for 5 days followed by 24 hour co-exposure to CORT and 
METH resulted in significant toxicity within the VTA (~135% vehicle control; p<0.001).  
The observed CORT + METH-induced toxicity within the VTA was significantly 
attenuated by co-exposure to the NMDA receptor antagonist APV during the 24 hour co-
exposure period (p<0.05).  However, significant toxicity was also observed following 
either 6 day exposure to CORT alone (~120% vehicle control; p<0.01) or 24 hour 
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exposure to METH in vehicle pre-treated co-cultures (~120% vehicle control; p<0.01).  
Further, the observed CORT- or METH-induced toxicity was modestly attenuated by co-
exposure to APV, although not to significant levels.  Representative images of PI uptake 
in triple slice co-cultures exposed to CORT + METH are presented in Figure 2.3. 
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Figure 2.2. Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to 24 hour co-exposure to either vehicle/CORT along with 100 µM METH + 50 µM 
APV on PI uptake within the medial prefrontal cortex (mPFC; A), nucleus accumbens 
(NAcc; B) or ventral tegmental area (VTA; C).  Pre-treatment with CORT and co-
exposure to METH resulted in significant neurotoxicity in the mPFC, an effect which was 
not seen in vehicle pre-treated cultures.  Co-exposure to the competitive NMDA receptor 
antagonist APV prevented the METH-induced cytotoxicity in CORT pre-treated cultures 
in the mPFC region.  Dashed line represents DMSO-treated value. Data represented as 
percentage of DMSO-treated cultures (mean ± SEM).* p<0.05 vs. DMSO (vehicle) 
levels; # p<0.05 vs. CORT + METH 
C 
A 
B 
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Figure 2.3. Representative images of PI uptake in co-cultures of the medial prefrontal 
cortex (mPFC), nucleus accumbens (NAcc) and ventral tegmental area (VTA) pretreated 
with either DMSO or CORT and co-exposed to METH (100 µM) or METH + APV (50 
µM) for 24 hours. 
  
NAcc 
VTA 
mPFC 
CORT 
CORT+METH+APV 
NAcc 
VTA 
mPFC 
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Effects of CORT on METH-induced NeuN Immunoreactivity (Figures 2.4 and 2.5) 
This experiment was designed to examine losses in immunoreactivity of the 
neuronal nuclear protein (NeuN) following 5 days of previous CORT pre-exposure 
followed by 24 hours of co-exposure to CORT and METH.  There was no difference in 
NeuN immunoreactivity between sexes within each treatment group, and male and 
female data were combined for further analysis.  Thus, a one-way ANOVA for treatment 
was conducted within each region of interest.  Within the mPFC, no significant main 
effect of treatment was observed (Figure 2.4A; F(7, 92)=0.643, p>0.05).  Similarly, in the 
NAcc as well as the VTA, no significant main effects were observed (Figure 2.4B and 
2.4C, respectively; F(7, 92)=0.848, p>0.05 for NAcc; F(7, 92)=0.801, p>0.05 for VTA).  
Representative images of NeuN immunoreactivity in triple slice co-cultures exposed to 
CORT + METH are presented in Figure 2.5. 
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Figure 2.4.  Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to 24 hour co-exposure to either vehicle/CORT along with 100 µM METH + 50 µM 
APV on immunoreactivity of neuronal nuclear protein (NeuN) within the medial 
prefrontal cortex (mPFC; A), nucleus accumbens (NAcc; B) or ventral tegmental area 
(VTA; C).  Pre-treatment with CORT and co-exposure to METH did not result in 
significant losses in NeuN immunoreactivity in any of the regions examined.    
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Figure 2.5. Representative images of immunoreactivity of neuronal nuclear protein 
(NeuN) in co-cultures of the medial prefrontal cortex (mPFC), nucleus accumbens 
(NAcc) and ventral tegmental area (VTA) pretreated with either DMSO or CORT and co-
exposed to METH (100 µM) or METH + APV (50 µM) for 24 hours.  No statistically 
significant group differences were observed.   
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Effects of CORT and METH on NR1 subunit density (Figures 2.6 and 2.7) 
A second set of experiments was conducted to assess the effects of 5 days of 
CORT pre-exposure followed by 24 hours of co-exposure to CORT and METH on the 
density of the obligatory NMDA receptor subunit 1 in triple slice co-cultures.  A one-way 
ANOVA for treatment revealed no significant main effect of treatment (Figure 2.6; F(3, 
16)=1.946, p>0.05).  Though not statistically significant, it is important to note that slight 
losses in NR1 density were observed in all METH-treated co-cultures (~80% vehicle 
treated control).  It must also be noted that although region-specific effects were observed 
in experiment 1, western blot analysis was conducted in homogenized tissue containing 
all three regions of interest.  A representative image of a western blot analysis for NMDA 
NR1 subunit density in triple slice co-cultures exposed to CORT + METH is presented in 
Figure 2.7. 
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Figure 2.6.  Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to 24 hour co-exposure to either vehicle/CORT along with 100 µM METH on NR1 
subunit protein density.   No statistically significant changes in NR1 western blot analysis 
were observed following the 5 day vehicle/CORT pre-treatment + 24 hour co-exposure to 
METH.   
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Figure 2.7. Representative image of western blot immunoblotting for the NMDA 
receptor NR1 subunit.   
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Effects of CORT and METH on NR2B subunit density (Figures 2.8 and 2.9) 
The second set of experiments also assessed the effects 5 days of CORT pre-
exposure followed by 24 hours of co-exposure to CORT and METH on the density of the 
polyamine sensitive NMDA receptor subunit 2B in triple slice co-cultures.  A one-way 
ANOVA revealed a significant main effect of treatment on NR2B subunit density (Figure 
2.8; F(3, 16)=4.065, p<0.05).  Similar to the losses observed in NR1 density, significant 
losses in NR2B density were observed in co-cultures pre-treated with either vehicle or 
CORT and co-exposed to vehicle/CORT and METH for 24 hours as compared to vehicle-
treated co-culture samples (~70% vehicle treated control, p<0.05).  Exposure to CORT 
for 6 days in the absence of METH did not significantly alter NR2B subunit density.  A 
representative image of a western blot analysis for NMDA NR2B subunit density in triple 
slice co-cultures exposed to CORT + METH is presented in Figure 2.9. 
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Figure 2.8.  Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to 24 hour co-exposure to either vehicle/CORT along with 100 µM METH on 
NMDA receptor NR2B subunit protein density.   Exposure to METH for 24 hours 
significantly reduced NR2B subunit density as measured by western blot analysis 
regardless of pretreatment (DMSO/CORT).  Dashed line represents DMSO-treated value. 
Data represented as percentage of DMSO-treated cultures (mean ± SEM).* p<0.05 vs. 
DMSO (vehicle) levels 
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Figure 2.9. Representative image of western blot immunoreactivity for the NMDA 
receptor NR2B subunit.   
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Effects of CORT and METH on HPLC analysis of extracellular dopamine (Figures 2.10 
and 2.11) 
Experiment 2C was designed to assess the effects of 5 days of CORT pre-
exposure followed by 24 hours of co-exposure to CORT and METH on extracellular DA 
and GLUT levels, and to examine the potential role of the NMDA receptor in any CORT-
induced augmentation of DA and GLUT levels in response to acute METH.  Experiment 
2C focused on extracellular DA levels in triple slice co-cultures co-exposed to CORT and 
METH for 24 hours in the presence of the NMDA receptor antagonist APV.  A one-way 
ANOVA revealed no significant main effect of treatment on DA HPLC (Figure 2.10; F(7, 
63)=1.075, p=0.390).  However, it is important to note that METH-treated cultures (both 
vehicle- and CORT-pretreated) had extracellular dopamine levels equal to approximately 
80-85% of vehicle control values, suggesting the possibility of slight dopaminergic 
toxicity.  A representative image of a chromatograph for DA HPLC analysis using ACSF 
samples collected from triple slice co-cultures exposed to CORT + METH is presented in 
Figure 2.11. 
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Figure 2.10.  Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to co-exposure to either vehicle/CORT along with 100 µM METH on extracellular 
dopamine levels in artificial cerebrospinal fluid samples collected 45 minutes post-
METH.   There were no statistically significant changes in extracellular dopamine 
following CORT and/or METH exposure.  Dashed line represents DMSO-treated value. 
Data represented as percentage of DMSO-treated cultures (mean ± SEM). 
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Figure 2.11. Representative image of DA HPLC chromatograph using ACSF samples 
collected from triple slice co-cultures exposed to CORT + METH, showing a vehicle-
treated control (white) and a 6 nM DA standard (blue).    
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Effects of CORT and METH on HPLC analysis of extracellular glutamate (Figures 2.12 
and 2.13) 
Experiment 2C was designed to assess the effects of 5 days of CORT pre-
exposure followed by 24 hours of co-exposure to CORT and METH on extracellular DA 
and GLUT levels, and to examine the potential role of the NMDA receptor in any CORT-
induced augmentation of DA and GLUT levels in response to acute METH.  Experiment 
2C focused on extracellular GLUT levels in triple slice co-cultures co-exposed to CORT 
and METH for 24 hours in the presence of the NMDA receptor antagonist APV.  A one-
way ANOVA revealed a significant main effect of treatment on GLUT HPLC (Figure 
2.12; F(7, 67)=60.535, p<0.001).  Five day pre-exposure to CORT followed by 45 minute 
co-exposure to CORT and METH resulted in a significant decrease in extracellular 
GLUT levels compared to vehicle-pretreated co-cultures (~75% vehicle control; Fisher’s 
LSD post-hoc, p<0.001).  Further, neither CORT alone nor vehicle + METH produced 
any significant changes in extracellular GLUT levels compared to vehicle controls.  The 
decrease in extracellular GLUT levels following CORT + METH exposure was 
significantly different than that seen with CORT (p<0.01).  The observed CORT and 
METH-induced decrease in extracellular GLUT was significantly reversed by co-
exposure to the NMDA receptor antagonist APV during the 45 minute co-exposure 
period (p<0.001).  In fact, all APV-treated cultures had significantly higher levels of 
extracellular GLUT compared to vehicle controls (~145-165% vehicle control; p<0.001).  
The combination of CORT + METH + APV was not significantly lower than the 
combination of vehicle (DMSO) + METH + APV (p=0.196), but was significantly lower 
compared to CORT + APV or vehicle + APV (p<0.01).  A representative image of a 
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chromatograph for GLUT HPLC analysis using ACSF samples collected from triple slice 
co-cultures exposed to CORT + METH is presented in Figure 2.13. 
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Figure 2.12.  Effects of 5 day pre-treatment with either vehicle (DMSO) or 1 µM CORT 
prior to co-exposure to either vehicle/CORT along with 100 µM METH on extracellular 
glutamate levels in artificial cerebrospinal fluid samples collected 45 minutes post-
METH.   Exposure to METH in CORT-pretreated cultures resulted in a significant loss of 
extracellular glutamate compared to vehicle-pretreated cultures; this effect was 
significantly altered by co-exposure to the NMDA receptor antagonist APV during 
METH.  Dashed line represents DMSO-treated value. Data represented as percentage of 
DMSO-treated cultures (mean ± SEM).* p<0.05 vs. DMSO (vehicle) levels; # p<0.05 vs. 
CORT + METH 
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Figure 2.13. Representative image of GLUT HPLC chromatograph using ACSF samples 
collected from triple slice co-cultures exposed to CORT + METH, showing a vehicle-
treated control (yellow) and a 10 nM GLUT standard (green).    
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CHAPTER 4 
DISCUSSION 
Enhanced Toxicity Following CORT and NMDA Exposure 
Previous findings have suggested that 24 hour CORT co-exposure can 
significantly exacerbate the toxicity associated with the overactivation of the NMDA 
receptor in the hippocampus in a NMDA receptor-dependent manner (Mulholland et al., 
2006).   Notably, these earlier findings reported that this effect was independent of GR 
activation and was cyclohexamide insensitive. Further studies have investigated the role 
of the MR and GR in the ability of chronic CORT exposure to potentiate NMDA-induced 
cytotoxicity.  Mulholland et al. (2004b) found that chronic co-exposure to CORT in the 
presence of the GR antagonist mifepristone, but not the MR antagonist spironolactone, 
attenuated subsequent NMDA receptor-mediated toxicity.  The present studies 
(experiment 1) extend those by investigating the potential CORT-induced changes in 
response to an excitotoxin in regions critical to reward.  Results from experiment 1 
demonstrate that chronic pre-treatment with CORT exacerbated NMDA receptor-
mediated neurotoxicity in the VTA, but not the NAcc.  Further, this effect was dependent 
upon the NMDA receptor, as co-exposure to the NMDA receptor antagonist APV during 
NMDA exposure prevented the CORT-induced potentiation.  Additional studies also 
demonstrated that the ability of CORT to potentiate NMDA-induced neurotoxicity within 
the VTA was dependent upon GR activation, as co-exposure to the GR antagonist 
mifepristone during CORT exposure significantly attenuated the subsequent NMDA 
receptor-mediated toxicity.  Although previous studies have suggested a potential role for 
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plasma membrane-bound CORT receptors (Xiao, Feng, & Chen, 2010), the present data 
demonstrate the importance of intracellular GR binding in mediating the effects of CORT 
in this reward pathway.  The ability of CORT to potentiate subsequent NMDA receptor-
mediated excitotoxic insults within areas of the brain key to drug reward and 
reinforcement may be of crucial importance as several drugs of abuse, such as METH, 
cocaine, and withdrawal from ethanol, are known to produce increases in extracellular 
GLUT release within the striatum resulting in neurotoxicity (Abekawa, et al., 1994; 
Rossetti & Carboni, 1995; Rossetti, Carboni, & Fadda, 1999; Wakabayashi & Kiyatkin, 
2012).  Taken together, these findings suggest that chronic elevations in CORT may 
sensitize ventral tegmental neurons to subsequent excitatory effects of drugs of abuse and 
that NMDA receptors may serve as a viable therapeutic target for individuals with 
chronically elevated levels of cortisol (i.e. in individuals with stress disorders such as 
PTSD).   
Regional Differences in CORT + NMDA-induced Toxicity 
 It is interesting to note that CORT-induced potentiation of NMDA receptor-
mediated neurotoxicity only occurred in the VTA and not in the NAcc.  This does not 
likely reflect differences in NMDA receptor binding as previous reports have found 
evidence for a higher density of NMDA receptor binding sites in the NAcc compared to a 
low relative density in the VTA (Albin et al., 1992).  Additional studies have examined 
the distribution of subunit-specific antibodies for the NMDA receptor and also found no 
significant differences in the distribution of NR2A nor NR2B within the NAcc and VTA 
(Wang et al., 1995), although the polyamine sensitive NR2B subunit appears to be the 
most prevalent subunit in mesencephalon cultures, as compared to the NR2A, NR2C, and 
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NR2D subunits (Allgaier, Scheibler, Muller, Feuerstein, & Illes, 1999).  Notably, as the 
NR2B subunit is sensitive to polyamine synthesis, CORT has also been shown to dose-
dependently increase polyamine expression within the hippocampus (Ientile, De Luca, Di 
Giorgio, & Macaione, 1988), thus providing a possible mechanism for the regional 
specificity for CORT effects within the VTA.  One alternative hypothesis is that there is a 
differential distribution of GRs between the NAcc and VTA.  Although the distribution of 
GRs is often thought to be ubiquitous throughout much of the rodent brain, results from 
previous studies have been mixed regarding distribution within the NAcc and VTA.  For 
example, Aronsson et al. (1988) found moderate levels of GR mRNA in the VTA 
compared to weak GR mRNA in the NAcc.  Most studies, however, have found 
approximately equal distribution of GRs via immunohistochemistry and/or in situ 
hybridization within the striatum and midbrain regions (Ahima & Harlan, 1990; 
Morimoto, Morita, Ozawa, Yokoyama, & Kawata, 1996).  Additionally, several studies 
have noted strong immunoreactivity for the GR among dopaminergic neurons, especially 
those originating in the VTA (Barik et al., 2010; Diaz, Sokoloff, & Fuxe, 1997; 
Harfstrand, et al., 1986). 
Glucocorticoid Receptor-Dependent Toxicity Following CORT and NMDA Co-exposure  
 The results of the current study are in agreement with a large body of literature 
implicating the importance of the GR in the CORT-induced potentiation of a future insult 
(Alexander, DeVries, Kigerl, Dahlman, & Popovich, 2009; Mulholland, et al., 2004a, 
2004b), although the exact mechanism by which CORT may enhance neuronal 
vulnerability to future insults is not yet well defined.  Research suggests that long-term 
exposure to high levels of circulating glucocorticoids may increase the expression and/or 
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function of the NMDA receptor subunits (Karst & Joels, 2003; Prendergast & 
Mulholland, 2012; Weiland, et al., 1997).  In addition, high concentrations of CORT have 
been shown to result in increased intracellular levels of Ca
2+
 (Karst, Wadman, & Joels, 
1994; Kerr, Campbell, Thibault, & Landfield, 1992) as well as induce the release of 
GLUT and other excitatory amino acids (Moghaddam, Bolinao, Stein-Behrens, & 
Sapolsky, 1994; Stein-Behrens et al., 1992; Stein-Behrens, Lin, & Sapolsky, 1994). 
Notably, the use of mifepristone in the current study does not preclude the role of 
progesterone receptors in the observed results as mifepristone, in addition to its action at 
the GR, is a progesterone receptor antagonist.  Future experiments with a more selective 
GR antagonist are necessary to rule out the possibility that progesterone receptor 
antagonism protects against CORT and NMDA-induced toxicity.  Although other 
mechanisms cannot be ruled out, the results of the current study in conjunction with 
several previous studies suggest that chronic CORT may lead to increased neuronal 
vulnerability to future excitotoxic insults via increased NMDA receptor expression and/or 
function.   
Stress Exacerbates METH-induced Toxicity  
 Many in vivo studies have noted toxicity following high doses of METH, an effect 
which is further perturbed by chronically stressing the animal prior to METH 
administration.  In particular, in a study by Nash and Yamamoto (1992) rats were given 3 
injections of 7.5 mg/kg (i.p.) of METH every 2 hours during microdialysis.  Repeated 
METH administration resulted in increased extracellular GLUT concentrations in the 
striatum compared to saline or ecstasy (MDMA) administration.  In contrast, DA 
concentrations within the striatum were also measured using microdialysis and were 
84 
 
increased following each injection of both METH and MDMA.  Seven days after the 
repeated METH or MDMA administration, DA content within the striatum was 
measured; repeated METH resulted in decreased DA content compared to vehicle, 
whereas repeated MDMA administration had no effect on DA content in the striatum.  
Taken together, these results suggest that long term METH-induced dopaminergic 
toxicity is, in part, mediated by GLUT.  Previous exposure to chronic stress can 
exacerbate METH-induced increases in striatal GLUT and decreases of striatal DA 
content.  Recently, Tata and Yamamoto (2008) found that animals previously exposed to 
a 10-day chronic unpredictable stress paradigm showed enhanced striatal extracellular 
GLUT concentrations in response to METH.  Similarly, previous exposure to chronic 
stress exacerbated the METH-induced decrease in DA content within the striatum.  
Further, only animals in the chronically stressed condition and subsequently given the 
METH regimen showed increases in spectrin breakdown product, which may be 
indicative of NMDA receptor-mediated activation of calpains and related cysteine 
proteases.   As these in vivo studies illustrate the enhanced vulnerability to METH-
induced toxicity resulting from stress (and probable elevations in glucocorticoids), the 
current studies examined the effect of CORT pre-exposure on toxicity following acute 
METH exposure using an in vitro model of the mesocorticolimbic reward pathway.  In 
kind with previous studies, we hypothesized that co-cultures exposed to CORT and 
METH would be most vulnerable to damage compared to co-cultures exposed to either 
CORT or METH independently.  Additionally, we hypothesized that the damage caused 
by the combination of CORT and METH would be NMDA receptor-dependent and a 
result of neuroadaptations in the obligatory NR1 and polyamine sensitive NR2B subunits 
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of the glutamatergic NMDA receptor.  A final set of experiments investigated the ability 
of antagonism of the NMDA receptor to prevent the CORT-induced potentiation of 
METH-evoked DA and GLUT overflow.   
Toxicity Following CORT and Acute METH Co-exposure  
 The current data demonstrate that 5 day pre-exposure to CORT followed by 24 
hour co-exposure to CORT and METH results in significant toxicity within the mPFC 
region, with CORT+METH co-exposure resulting in increased PI uptake by 
approximately 40-50% above vehicle-treated values.  Further, the toxicity observed 
following CORT+METH co-exposure was significantly elevated compared to toxicity 
observed in cultures exposed to either CORT or METH independently.  The current 
studies also demonstrate the importance of the NMDA receptor in CORT+METH-
induced toxicity, as co-exposure to the NMDA receptor antagonist APV during 
CORT+METH exposure attenuated the observed toxicity.  No significant toxicity was 
observed in the NAcc region following CORT, METH, or CORT+METH exposure.  In 
contrast, within the VTA, significant toxicity was observed following either CORT or 
METH exposure (~20% above vehicle control values) while co-exposure to 
CORT+METH resulted in toxicity slightly greater that seen with either CORT or METH 
alone (~40% above vehicle-treated cultures).  The additive toxic effects of CORT and 
METH in the VTA were significantly attenuated by co-exposure to APV during 
CORT+METH co-exposure.    
 In contrast to the current dataset which did not identify cytotoxicity in the 
striatum, several rodent studies have shown enhanced toxicity in the striatum following 
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stress or CORT and METH exposure (Matuszewich & Yamamoto, 2004a, 2004b; 
Quinton & Yamamoto, 2007; Raudensky & Yamamoto, 2007b; Tata, Raudensky, & 
Yamamoto, 2007; Tata & Yamamoto, 2008).   However, it must be noted that significant 
methodological differences exist between the aforementioned in vivo studies and the 
current set of experiments.  For example, many in vivo studies have used the chronic 
unpredictable stressor paradigm to induce stressful conditions and a resulting rise in 
CORT levels whereas the current study maintained a steady level of CORT prior to 
METH treatment in the culture system.  Notably, in vivo high-dose METH is also known 
to produce hyperthermia (Ali, Newport, & Slikker, 1996; Miller & O'Callaghan, 2003), 
while the current in vitro studies maintained all cultures at 37°C.  Further, many in vivo 
studies have focused on the long-term METH-induced dopaminergic terminal toxicity 
observed within the striatum (Matuszewich & Yamamoto, 2004a, 2004b; Quinton & 
Yamamoto, 2007; Raudensky & Yamamoto, 2007b; Tata, et al., 2007; Tata & 
Yamamoto, 2008); the current results suggest that the mPFC and VTA may be 
preferentially vulnerable to the short-term toxic effects of METH.  Recently, Kelly and 
colleagues (2012) showed that mice pre-treated with CORT exhibited an enhanced 
striatal neuroinflammatory and neurotoxic response to an acute high-dose METH 
regimen; consistent with the current data, however, chronic CORT pre-treatment also 
sensitized the frontal cortex and the hippocampus to the neurotoxic effects associated 
with METH.  Collectively, these data reveal the enhanced toxicity associated with the 
combination of CORT and METH, although discrepancies remain as to regional 
vulnerability.     
 
87 
 
NMDA Receptor Antagonism Protects Against CORT + METH-induced Toxicity 
 Prior literature has been divided as to the protection of METH-induced damage 
provided by antagonism of the NMDA receptor.  Staszewski and Yamamoto (2006) 
found that repeated high-dose METH caused an increase in calpain-mediated spectrin 
proteolysis in the rodent striatum up to seven days following repeated METH 
administration; the METH-induced increase in spectrin proteolysis was attenuated by 
AMPA, but not NMDA, receptor antagonism.  Further, neither AMPA nor NMDA 
receptor antagonists blocked METH-induced reductions in striatal DAT content 
(Staszewski & Yamamoto, 2006).  Previous studies have demonstrated the 
neuroprotective effects of NMDA receptor antagonists against METH-induced toxicity 
(Sonsalla, 1995; Sonsalla, et al., 1991);  however, in vivo studies have also revealed the 
importance of hyperthermia in METH-induced toxicity and the protection of such 
hyperthermia afforded by NMDA receptor antagonism (Miller & O'Callaghan, 2003). 
The current results suggest that, independent of hyperthermia, NMDA receptor 
antagonists may be useful in attenuating toxicity associated with CORT and/or METH.   
Regional Differences in CORT + METH-induced Toxicity 
The current study demonstrated region-specific effects of the combination of 
CORT and METH, including enhanced cytotoxicity following chronic CORT and acute 
METH exposure only in the mPFC.  Although the current study did not examine regional 
differences in receptor distribution, the frontal cortex and mPFC has been reported to 
contain greater levels of the NMDA receptor compared to either the NAcc or VTA 
(Sakurai, Cha, Penney, & Young, 1991; Takita, Yokoi, & Mizuno, 1997).  Additional 
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reports have suggested a high expression of mRNA for the NR2B subunit as well as high 
NR2B protein levels in the PFC compared to the NAcc (Loftis & Janowsky, 2003; 
Monyer, Burnashev, Laurie, Sakmann, & Seeburg, 1994; Wenzel, Fritschy, Mohler, & 
Benke, 1997).  Further, the vulnerability of the mPFC to CORT and METH-induced 
toxicity may be related to distribution of the GR.  Previous studies in non-human 
primates showed that the PFC contains surprisingly high levels of GR mRNA (Sanchez, 
Young, Plotsky, & Insel, 2000).  Consistent with the theory of regional differences in GR 
protein, recent work has shown that GR antagonism by RU-43044 prevents METH-
induced increases in extracellular prefrontal DA levels whereas RU-43044 had no effect 
on extracellular DA levels measured in the NAcc shell (Ago et al., 2009).  Further, prior 
stress synergistically enhanced lipopolysaccharide-induced neuroinflammation in the 
mPFC while GR antagonism by RU-486 protected against the combination of stress and 
lipopolysaccharide (de Pablos et al., 2006).  Together, these results suggest that the 
mPFC may be particularly vulnerable to the combination of CORT and METH as a result 
of increased expression of GR or NMDA receptors. 
Toxic Effects of METH in the VTA  
 The present studies revealed a region-specific vulnerability of the VTA to the 
toxic effects associated with exposure to either CORT or METH independently.  
Contradictory to the current results, cresyl violet staining of Nissl bodies in the VTA and 
substantia nigra revealed no effect of repeated METH (Ricaurte, Guillery, Seiden, 
Schuster, & Moore, 1982).  Similarly, adult rodents exposed to three administrations of 
METH (10 mg/kg every 2 hours) had no significant changes in DA and serotonin levels 
in the VTA, substantia nigra, PFC, or hippocampus while METH significantly depleted 
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striatal DA and serotonin by 65% and 79%, respectively (Bisagno, Ferguson, & Luine, 
2002).  Keller and colleagues (2011) found a significant increase in DA tissue content in 
the VTA, as well as an accompanying significant decrease in the NAcc, 48 hours 
following escalating (0.1 – 4 mg/kg/day) or binge (3 injections of 4 mg/kg per day) 
METH administration.  Further, both escalating and binge METH resulted in opposing 
responses in tissue taken 2 weeks post-METH compared to that taken 48 hours post-
METH, including significant decreases in VTA DA content and increases in NAcc DA 
tissue content.  The reported changes in DA tissue content in the NAcc and VTA 
paralleled findings of tyrosine hydroxylase-positive tissue content as a biphasic response 
to escalating and binge METH was also observed.  However, within the whole striatum, 
neither escalating METH doses nor binge METH altered levels of DA or tyrosine 
hydroxylase tissue content.  Additionally, DAT immunoreactivity was altered in a 
biphasic manner in the VTA, but was unchanged in the NAcc, striatum, or substantia 
nigra, following METH (Keller, et al., 2011).  Taken together, these studies in 
conjunction with the current results reveal the region-specific vulnerability of the VTA to 
high concentrations of METH.   
Toxic Effects of CORT in the VTA  
 Similar to the METH-induced effects occurring preferentially in the VTA, chronic 
CORT exposure also resulted in significant increases in PI uptake in the VTA, but not the 
NAcc or mPFC, in the current set of experiments.  Contrary to the present results, 
Mesquita and colleagues (2007) reported that maternal separation for 14 days during the 
early post-natal period did not alter DA turnover nor DA or its metabolites, DOPAC and 
HVA, in the VTA (although a significant increase in DOPAC was found in females 
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exposed to maternal separation compared to their control counterparts).  Additionally, 
stress via maternal separation did not significantly alter TH-positive or tryptophan 
hydroxylase-positive immunocytochemistry in either the VTA or the dorsal raphe nuclei 
(Mesquita, et al., 2007).  Haneyuki et al. (1991) reported a slight, but significant, increase 
in DOPAC levels in the VTA following exposure to a brief (10 min) psychological social 
stressor and a rise in DOPAC levels in the mPFC following a longer exposure to the 
social stressor (30 min), suggesting that acute stressors may result in oxidative stress via 
DA metabolism.  These results suggest that CORT-induced activation of DA neurons 
within the VTA may precede that in terminal areas of projection, such as the mPFC 
(Kaneyuki, et al., 1991).  In concert with these previous reports, the current results 
suggest that the VTA may be selectively vulnerable to the effects of stress and elevations 
in CORT levels compared to other regions of the mesocorticolimbic pathway.     
CORT, METH, and CORT + METH Failed to Alter Levels of NeuN Immunoreactivity 
Unexpectedly and contrary to the hypothesis, the current studies revealed no 
significant treatment effect on immunoreactivity of the neuronal nuclear protein, NeuN.   
Although few studies have investigated the effects of acute METH on NeuN 
immunoreactivity, one recent study found that METH (30 mg/kg) administration in mice 
resulted in increased apoptosis in approximately 25% of striatal neurons as evidenced by 
decreased NeuN and increased terminal deoxynucleotidyl transferase-mediated dUTP 
nick end labeling (TUNEL) staining (Zhu, Xu, & Angulo, 2006).  Additionally, 
vulnerability to METH-induced apoptosis was dependent upon subpopulation as only 
21% of DA- and cAMP-regulated projection neurons showed apoptosis compared to 45% 
of GABA and 29% of cholinergic interneurons (Zhu, et al., 2006).  Consistent with the 
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current results, repeated administration of METH (5 mg/kg for 10 days) during 
development in adolescent mice resulted in no significant changes in NeuN 
immunoreactivity within the basal forebrain (Siegel, Park, & Raber, 2011); further, 
repeated METH exposure did not significantly alter levels of GABAergic or 
acetylcholinergic neurons in the basal forebrain.   Although several methodological 
differences exist between the aforementioned studies and the current experiment, future 
studies should investigate the timecourse associated with a loss of NeuN 
immunoreactivity following a neurotoxic regimen of METH.   
CORT and METH Co-exposure: Potential Neuroadaptations in NMDA receptor subunit 
NR1 
The current study revealed no significant changes in NR1 density via western blot 
analysis following CORT, METH or the combination of CORT and METH.  Although no 
study to date has examined the effects of concurrent exposure to CORT and METH on 
NR1 subunit density, the present results suggest that NR1 density remains largely 
unaltered following co-exposure to CORT and METH, although it must be noted that 
METH exposure resulted in slight decreases in NR1 regardless of pre-treatment.  The 
lack of literature on this topic is surprising given that both CORT and METH individually 
purportedly result in alterations in the NR1 subunit (see below).  However, extensive 
research suggests that regional differences exist in NMDA receptor expression, including 
the NR1 subunit (Luo, Bosy, Wang, Yasuda, & Wolfe, 1996).  As the current western 
blot experiments did not allow for detection of regional differences, the possibility that 
CORT and METH act in concert to significantly alter NR1 subunit density in a region-
specific manner cannot be ruled out.   
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Methamphetamine Exposure: Potential Neuroadaptations in NMDA receptor subunit 
NR1 
Whereas previous studies investigating the effects of METH on NR1 have yielded 
mixed results, the current study found no significant changes in NR1 density following 
acute METH exposure.  Western blot analysis for the NR1 subunit revealed that subacute 
exposure to METH (4 mg/kg/day for 14 days) resulted in upregulation in the frontal 
cortex while both acute (8 mg/kg) and subacute exposure resulted in upregulation of NR1 
in the striatum (Kerdsan, et al., 2009).  Further, no significant effects of either acute or 
subacute METH were observed in the hippocampus (Kerdsan, et al., 2009).  Simoes and 
colleagues (2007) also showed upregulation of NR2A expression and no change in NR1 
expression when METH was given acutely, and a downregulation of NR1 expression and 
no change in NR2A expression when METH was given in escalating doses.  Protracted 
withdrawal of 14 days, but not 3 days, from amphetamine administration has also been 
shown to reduce NR1 subunit density in the VTA, NAcc and PFC, accompanied by a 
significant decrease in NR1 mRNA only evident in the PFC (W. Lu, Monteggia, & Wolf, 
1999).  Although not statistically significant, the current study saw a slight decrease in 
NR1 density in samples containing the VTA, NAcc, and mPFC following 24 hour 
exposure to METH.   
Corticosterone Exposure: Potential Neuroadaptations in NMDA receptor subunit NR1 
Similar to the effects of METH on NR1 subunit density, the lack of significant 
changes in NR1 protein levels following chronic CORT observed in the current set of 
experiments is in contrast to previous reports, although the literature is mixed in regards 
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to direction.  Cohen et al. (2011) reported a 47% decrease in NR1 protein levels in the 
postsynaptic density subsynaptic fraction of adult mice following implantation with a 
CORT pellet for 21 days.  In contrast, a persistent upregulation of the NR1 and NR2A 
subunits in the hippocampus followed early-life maternal separation stress when 
examined in young (3 months) and aged (18 months) rats (Martisova et al., 2012).   In 
agreement with the current results, Weiland and colleagues (1997) saw no differences in 
NR1 subunit density in the hippocampus of rats following 10 day subcutaneous 
implantation with a CORT pellet.  Together, the current results along with previous 
studies, largely involving the hippocampus, demonstrate the regional differences in NR1 
subunit density following chronic stress or CORT exposure.  Indeed, a recent review 
paper detailed many differences in glutamatergic transmission, including receptor and 
release differences (Popoli, Yan, McEwen, & Sanacora, 2012).  For example, Yuen and 
colleagues (2012) showed that surface and total NR1 was decreased up to 70% in the 
PFC, but not the striatum or hippocampus, following seven days of repeated restraint 
stress.  Further, the effects of chronic restraint stress on NR1 density in the PFC was 
shown to be dependent upon GR activation as administration of the GR antagonist RU-
486 attenuated the observed loss, suggesting that the GR, in part, modulates GLUT 
receptor expression in the PFC following repeated stress (Yuen, et al., 2012).  Given 
evidence for such regional discrepancies, future experiments should investigate the 
effects of chronic CORT on individual regions such as the mPFC, NAcc, and VTA.  
Collectively, these studies demonstrate the complexity of glutamatergic receptor density 
following both CORT and METH exposure.   
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Corticosterone and Methamphetamine Co-exposure: Potential Neuroadaptations in 
NMDA receptor subunit NR2B 
Although no study to date has examined the effects of concurrent CORT/stress 
and METH on NR2B subunit density, the present results suggest that previous CORT has 
no relation to subsequent METH-induced decreases of NR2B density.  This finding is 
surprising given that both CORT and METH individually produce alterations in the 
NR2B subunit as well as the NR1 subunit as previously discussed.  However, there is 
strong evidence that regional differences exist, both in toxicity and receptor subunit 
expression, that may underlie this conundrum.  One limitation to the current western blot 
experiments is that it does not allow for regional differences to be examined.  Indeed, 
select regional vulnerabilities were observed in the current set of studies such that the 
mPFC and VTA appear to be more susceptible to CORT- and METH-induced toxicity 
compared to the NAcc.  In conjunction with previous reports supporting regional 
differences in NMDA receptor subunits following stress or CORT exposure (Popoli, et 
al., 2012), these studies reveal the importance of investigations detailing both the 
individual and combined effects of CORT and METH in several independent regions of 
the brain.  Together, these studies demonstrate the complexity of glutamatergic receptor 
density, in particular, the polyamine-sensitive NR2B subunit, following both CORT and 
METH exposure.   
Methamphetamine Exposure: Potential Neuroadaptations in NMDA receptor subunit 
NR2B 
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While chronic CORT did not significantly alter the density of the polyamine-
sensitive NR2B subunit of the NMDA receptor, METH exposure for 24 hours did result 
in significant decreases in NR2B density regardless of pre-treatment (DMSO vs. CORT).  
The decrease in NR2B protein levels observed following METH in current studies are in 
contrast to the hypothesis and to results previously reported.  Davidson and colleagues 
(2007) found that a neurotoxic regimen of METH did not alter NR2B subunits or their 
phosphorylation state in the caudate, but did significantly increase levels of PFC NR2B, 
in addition to increasing AMPA GluR1 subunits and phosphorylated subunits, in adult 
male rats.  Similarly, mice exhibiting conditioned place preference following intermittent 
METH also had increased expression of NR1, NR2A, and NR2B in the lower midbrain 
region (Kurokawa et al., 2011).  Given the previous reports indicating increased 
polyamine-sensitive NR2B expression following METH, it is surprising the current study 
did not achieve similar results.  However, significant methodological differences exist 
between the current study and the aforementioned reports, including METH regimen and 
regions examined, which may be responsible for the inconsistencies.   
Corticosterone Exposure: Potential Neuroadaptations in NMDA receptor subunit NR2B 
The current results indicating no significant changes in NR2B subunit density 
following chronic exposure to CORT are in stark contrast to previous reports of 
upregulation of the polyamine sensitive subunit in the hippocampus.  Weiland and 
colleagues (1997) showed that subcutaneous implantation with a CORT pellet for 10 days 
increased levels of mRNA for both the NR2A and NR2B subunits in all regions of the 
hippocampus examined.  Consistent with the results from Weiland et al., Klug and 
colleagues (2012) showed that chronic treatment with CORT in the drinking water for 3 
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weeks resulted in a significant increase in NR2B levels within the dorsal hippocampus of 
mice.  In kind with the current NR2B results, another recent study found that NR1 and 
NR2A, but not NR2B, density within the hippocampus was upregulated following early-
life maternal separation stress, an effect which was present in young rats and persisted 
into late adulthood up to 18 months (Martisova, et al., 2012).  Although many of the 
previous reports detailing the ability of CORT to upregulate NR2B expression and/or 
function have been conducted in the hippocampal region of the rodent brain, the current 
results suggest that these effects may be dependent upon the region examined and 
possibly the basal density of NMDA receptors containing the polyamine sensitive NR2B 
subunit, which is thought to be high in the hippocampus compared to other limbic 
structures (Loftis & Janowsky, 2003; Monaghan & Cotman, 1985).   
Effects of Combined CORT and METH on HPLC Analysis of Extracellular Dopamine  
  The current study revealed no significant changes in extracellular DA levels 
following CORT, METH or the combination of CORT and METH, although a slight, 
non-significant decrease in DA was observed following exposure to METH for 45 
minutes.   This is in contrast to the effects associated with dose-dependent increases in 
extracellular DA collected from co-cultures containing the VTA, NAcc, and mPFC 
following acute (30 min) exposure to METH, cocaine, or morphine (Nakagawa, et al., 
2011).  In this study, METH (100 or 1000 μM; lower concentrations did not significantly 
evoke a rise in DA) resulted in significant increases in extracellular DA.  However, the 
current study failed to evoke elevations in extracellular DA following acute exposure to a 
single concentration of METH (100 μM).  Further, Nakagawa and colleagues (2011) 
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revealed augmentation of extracellular DA following repeated exposure to METH in the 
triple slice co-culture model.  Although the current study did not investigate the effects of 
repeated METH on subsequent METH-induced changes in extracellular DA content, the 
present experiments did investigate the possible cross-sensitization between CORT and 
METH as several in vivo studies have demonstrated that prior stress can cross-sensitize 
the neurochemical and behavioral responses to METH (Piazza, et al., 1990; Piazza & Le 
Moal, 1997).  The current results are not in agreement with previous literature indicating 
a significant elevation in extracellular DA levels following METH nor reports suggesting 
CORT can enhance METH-evoked increases in extracellular DA.  Although the reasons 
behind said discrepancies are not yet clear, slight modifications (including age of pups 
when tissue collection was initiated) in the preparation of rat mesocorticolimbic triple 
slice co-cultures were undertaken in the current studies, compared to the methods utilized 
by Nakagawa and colleagues, that may be responsible for the differences.  
Effects of METH on HPLC Analysis of Extracellular Dopamine  
 Regardless of the discrepancies between the current results and previous reports, 
METH caused a slight, non-significant, decrease in extracellular DA levels compared to 
vehicle-treated controls, an effect which was not altered by prior exposure to CORT.  
This slight decrease may be indicative to mild dopaminergic toxicity occurring following 
exposure to high-concentration METH.  In agreement with this, mild, yet significant, 
toxicity was observed in the VTA area following acute METH in the present studies.  
Further indications of toxicity were significant decreases in NR2B subunit density 
following 24 hour METH exposure and slight, non-significant decreases in NR1 subunit 
density.  Since the samples collected for both western blot and extracellular DA content 
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analysis were collected from whole triple slice co-cultures, it is hard to discern whether 
dopaminergic toxicity was present in all of the regions or just select regions.  In sum, the 
present set of data indicates METH-induced dopaminergic toxicity in co-cultures. 
Effects of CORT on HPLC Analysis of Extracellular Dopamine  
 Acutely, CORT administration has been shown to increase levels of extracellular 
DA within the NAcc (Piazza et al., 1996).   However, previous reports have also shown 
that various stressors have differential influences on mesolimbic DA activity, with 
inescapable cold stress producing decreases in VTA DA neuron activity while restraint 
stress increased VTA DA neuronal activity (Valenti, Gill, & Grace, 2012).  Long-term 
exposure to stressors, such as that seen with the chronic unpredictable stress paradigm, 
has been shown to deplete extracellular DA levels within the NAcc (Gambarana et al., 
1999).  Similar to the results obtained in the current study, Finlay and colleagues (1995) 
showed that neither acute nor chronic stress altered basal levels of extracellular DA in the 
PFC, but rather altered levels in response to the benzodiazepine diazepam.   Given the 
range of effects on extracellular DA (within various regions of the brain) associated with 
stress or increases in CORT levels, the present finding that chronic CORT did not alter 
basal or METH-induced DA levels is not altogether unexpected.   Future experiments 
should investigate the possibility that CORT has region-specific effects on extracellular 
DA levels within the VTA, NAcc, and mPFC.   
Effects of Combined CORT and METH on HPLC Analysis of Extracellular Glutamate 
The present study revealed that chronic pre-exposure to CORT followed by acute 
exposure to METH for 45 minutes significantly decreased extracellular GLUT levels 
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compared to vehicle-treated controls.  The depressed levels of extracellular GLUT in 
response to CORT and METH were significantly different from that seen with CORT 
alone and a trend towards significance (p=0.10) compared to vehicle and METH was 
observed.  This is in stark contrast to the in vivo effects previously reported by the group 
of Yamamoto, suggesting that stress and METH act synergistically to enhance striatal 
GLUT (Matuszewich & Yamamoto, 2004a, 2004b; Quinton & Yamamoto, 2007; 
Raudensky & Yamamoto, 2007b; Tata, et al., 2007; Tata & Yamamoto, 2008).  Although 
the majority of previous reports have investigated GLUT levels in the hippocampus or 
striatum following stress and METH, the current results suggest that CORT exposure 
prior to and during acute METH may result in decreased extracellular GLUT within the 
mesocorticolimbic pathway.   
Perhaps not surprisingly, the combined effects of CORT and METH on 
extracellular GLUT were reversed by co-exposure to the NMDA receptor antagonist 
APV during CORT and METH exposure.  Notably, the effect of APV on extracellular 
GLUT was not specific to CORT and METH co-exposure, as APV treatment (regardless 
of prior exposure) significantly increased GLUT levels.  Although no significant effects 
of CORT, METH, or APV on extracellular DA levels were found, the slight decrease in 
extracellular DA observed following METH exposure was also reversed by co-exposure 
to APV.  Indeed, several studies have noted the interactions between GLUT and DA 
within areas of the mesocorticolimbic reward pathway.  In particular, Del Arco and Mora 
(Del Arco & Mora, 2001) showed that stimulation of prefrontal glutamatergic NMDA 
receptors dose-dependently reduced basal and stimulated DA release in the PFC.  Further 
investigations have revealed an opposite effect on DA levels within the NAcc such that 
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blockade of  NMDA receptors increased basal levels of DA and DA metabolites (Del 
Arco, et al., 2008).  Taken together, these studies suggest that GLUT receptors, and the 
NMDA receptor in particular, may be modulating extracellular levels of DA and GLUT 
within areas of the mesocorticolimbic pathway.   
Effects of METH on HPLC Analysis of Extracellular Glutamate 
Though many in vivo studies have found increases in extracellular GLUT within 
the rodent striatum following high doses of METH (Abekawa, et al., 1994; Bustamante et 
al., 2002; Mark, et al., 2004; Nash & Yamamoto, 1992; Stephans & Yamamoto, 1994), 
the finding that METH decreased GLUT levels, although opposite in nature to the 
hypothesis, is not without previous precedence.  Previous reports have suggested both a  
time- and region-dependent effect of acute METH on extracellular GLUT levels, such 
that, following an acute administration of METH (1 mg/kg), GLUT levels decreased in 
the VTA, substantia nigra compacta, and caudate-putamen while GLUT levels rose in the 
NAcc (Zhang, Loonam, Noailles, & Angulo, 2001).  Following seven days of METH (1  
mg/kg) administration, these effects were reversed to above baseline levels in the VTA, 
substantia nigra compacta, and caudate-putamen whereas the NAcc showed an increase 
of much less magnitude than following acute administration (Zhang, et al., 2001).  
Further, Pereira and colleagues (2012) showed that GLUT, GABA, and glutamine striatal 
tissue contents were significantly decreased 72 hours after a single administration of 
METH (30 mg/kg).  As many studies have shown the neurotoxic effects associated with 
METH, possibly resulting from excitotoxicity, it is of the utmost importance to determine 
the regional and time-dependent effects of both acute and chronic METH on extracellular 
GLUT.   
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Effects of CORT on HPLC Analysis of Extracellular Glutamate 
 Surprisingly, the current study found no effect of chronic CORT on extracellular 
GLUT.  Many investigations have noted enhanced extracellular GLUT in limbic and 
cortical areas, such as the PFC and NAcc, following exposure to acute stressors or 
elevation in CORT levels (Lowy, Wittenberg, & Yamamoto, 1995; Moghaddam, 1993; 
Reznikov et al., 2007; Venero & Borrell, 1999).  However, the effects of chronic stress or 
chronic CORT administration on extracellular GLUT levels are less well defined.  
Repeated tail-pinch stressors had no effect on extracellular GLUT levels within the 
hippocampus, while each subsequent stressor decreased extracellular GLUT levels within 
the PFC (Bagley & Moghaddam, 1997).  Thus, chronic stress may differentially alter 
levels of GLUT within the PFC compared to the hippocampus.  Future studies should 
investigate the effects of repeated exposure to stressors or CORT on extracellular GLUT 
within the PFC compared to mesolimbic structures, including the NAcc and VTA.   
Implications and Future Directions 
  Many studies have revealed parallel neuroadaptations following chronic stress or 
exposure to stimulants, such as METH.  Indeed, several human studies have shown that 
METH administration leads to persistent alterations in the stress hormone cortisol or 
HPA axis dysfunction (King, Alicata, Cloak, & Chang, 2010; Li et al., 2013).  Preclinical 
studies with non-human primates as well as rodents have shown that CORT levels remain 
elevated up to 24 hours following either acute or chronic METH administration (Grace et 
al., 2008; Madden et al., 2005).  Further, rodent models of amphetamine administration 
have shown that CORT levels, both basal and amphetamine-induced, are altered by 
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environmental stressors such as differential rearing conditions (Stairs, et al., 2011).  The 
present results suggest that the NMDA receptor may be implicated in CORT and METH-
induced toxicity within the mPFC, an area of the brain crucial to executive function and 
inhibitory control.  However, it is also important to note the significance of 
phosphorylation state when investigating the NMDA receptor, as tyrosine 
phosphorylation of the NR2B, but not the NR2A, subunit has been implicated in synaptic 
plasticity of the rat striatum (Lau & Huganir, 1995; Menegoz, Lau, Herve, Huganir, & 
Girault, 1995).  Future studies should investigate the possibility of increased expression 
of the polyamine sensitive NR2B subunit and the potential role of changes in 
phosphorylation state of the NMDA receptor in mediating the effects of chronic CORT 
within areas of the mesocorticolimbic pathway.  The current studies suggest that 
glutamatergic signaling and NMDA receptors may play a significant role in stimulant-
associated brain damage and cognitive disinhibition often associated with substance 
abuse.  Further, the present results suggest that antagonism of glucocorticoid or NMDA 
receptors may be valuable therapeutic targets in treating individuals with co-morbid 
METH dependence and HPA axis alterations.   
In conclusion, initial studies demonstrated that long-term exposure to a high, yet 
physiologically relevant, concentration of CORT can potentiate NMDA receptor-
mediated neurotoxicity within the VTA, but not the NAcc, in a GR-dependent manner.  
In agreement with previous data regarding hippocampal toxicity, these results suggest 
that chronic CORT may lead to an increase in the expression and/or function of NMDA 
receptor systems in an area of the brain that is critical for drug reward and reinforcement.  
A second set of experiments demonstrated that chronic CORT can sensitize the mPFC, 
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but not the NAcc or VTA, to subsequent METH-induced toxicity in a NMDA receptor-
dependent manner.  Co-exposure to CORT and METH also resulted in a significant 
decrease in extracellular GLUT, an effect which was reversed by NMDA receptor 
antagonism.  Together, these studies suggest that long-term exposure to CORT enhances 
glutamatergic signaling in response to future excitotoxic events, such as METH exposure, 
in areas of the brain critical for reward.   
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